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ORAL ABSTRACTS
Signalling in the control of inﬂammation and tissue repair
Anca Sindrilaru
Department of Dermatology and Allergic Diseases University of Ulm,
Germany
Proper leukocyte function at wound sites critically depends on adhesion mol-
ecules-mediated cell-cell and cell-matrix contacts. The involved membrane re-
ceptors and their downstream target molecules transducting signals to the
cytoskeleton have not been clariﬁed in detail yet. We here set out to deﬁne the
signalling pathways which are relevant for leukocyte recruitment and for the
intimate interaction between macrophages and apoptotic neutrophils during
tissue repair. Using our previously generated b2-integrin-deﬁcient mouse model
lacking the common b chain (CD18) of b2-integrins and closely resembling the
LAD1 syndrome in humans, we identiﬁed virtually abolished neutrophil re-
cruitment and impaired formation of the phagocytic synapse between apoptotic
neutrophils and macrophages. This resulted in reduced release of TGF-b1
which was causally responsible for reduced myoﬁbroblast-driven wound con-
traction and for delayed cutaneous wound healing. We now were able to iden-
tify the tyrosine-kinase Syk to relay signals from b2-integrins to the
cytoskeleton, thus coordinating b2-integrin-mediated neutrophil migration to
wounded skin. In addition, we have identiﬁed the guanine exchange factor
Vav3 as a target molecule acting downstream of b2-integrins and the Syk-kinase
in macrophages. Similar to CD18, Vav3 was required for the proper phagocytic
activation of macrophages to release TGF-b1 and to drive the myoﬁbroblast-
dependent wound contraction, and if absent, resulted in impaired wound heal-
ing, as observed in Vav3-deﬁcient mice.
Targeting signalling molecules responsible for leukocyte functions provides a
valuable tool to speciﬁcally modulate and rebalance inﬂammation and tissue
repair in vivo.
From bench to bedside: novel anti-inﬂammatory strategies
Nick L. Occleston, Amanda Knock, Sharon O’Kane, Mark W.J. Ferguson
Renovo, Core Technology Facility, Manchester, United Kingdom
Introduction: Scarring in the skin and at other body sites represents an area of
clear medical need. We have evaluated the role of interleukin-10 (IL-10) in
scarring and the scar improvement therapeutic potential of human recombinant
IL-10 in pre-clinical models and in a within-subject, double-blind, placebo and
standard care controlled phase II study in human volunteers.
Methods: Pre-clinical studies were performed in transgenic IL-10/Interleukin-4
(IL-4) double knockout mice and the eﬀects of intradermal administration of
IL-10 on scar formation (62.5–1000 ng/100 mL) was assessed macroscopically
and microscopically in rats at 70 days post-wounding. Pre-clinical safety and
toxicology studies were completed prior to initiation of the clinical study. The
human trial consisted of 175 subjects and evaluated the eﬀects of intradermal
administration IL-10 (5–2000 ng/100 mL), at the time of wounding and 24 hours
later, on safety and eﬃcacy endpoints
Results: Deletion of IL-10/IL-4 resulted in delayed healing, increased inﬂam-
mation and scarring. Interleukin-10 treatment of wounds in rats resulted in ac-
celerated healing, decreased inﬂammation and reduced scarring (po 0.05)
which was associated with the regeneration of a dermal architecture more re-
sembling normal skin. In humans administration of IL-10 was well tolerated
and at concentrations of 5 and 25 ng/100 mL resulted in statistically signiﬁcant
improvements (po 0.05) in scar appearance with multiple endpoints compared
with controls at 12 months after wounding.
Conclusions: These data indicate that acute, local applications of IL-10 im-
prove scarring both macroscopically and microscopically at the tissue level, and
is another example of the new class of emerging therapeutics for the prophy-
lactic improvement of scarring.
Inﬂammatory ulcers: topical and systemic treatment
Marco Romanelli
Wound Healing Research Unit, Department of Dermatology, University of
Pisa, Italy
Treatments for chronic wounds include systemic and topical agents. A good
balance between these two approaches has shown to produce a synergistic eﬀect
on tissue repair in certain type of chronic wounds. Recently new drugs have
been developed and introduced in the ﬁeld of wound healing. There are a large
number of potential interventions for inﬂammatory ulcers such as vasculitis or
pyoderma gangrenosum. The cornerstone of treatment is corticosteroids al-
though use of immunosuppressive agents, immunomodulatory agents, plas-
mapheresis, intravenous immunoglobulin, and biological agents has also been
described. Prolonged and high-dosage of these drugs are often required to at-
tain and maintain disease control, but this comes at a high price considering
side eﬀects. Safety of interventions must be considered alongside eﬃcacy, and
we have responsibility to seek treatments with lower complication rates.
Consensus leading to evidence based guidelines
Erwin Van der Heggen
Belgium
The management of healing wounds is very complex because of the diverse
aetiologies and comorbidities, the wide range of dressings, devices, drugs, sur-
gery and the variety of advanced therapies available in wound healing.
A consensus is an absolute base and a starting point to develop guidelines that
are based on scientiﬁc research. Therefore, high level evidence (meta-analysis of
multiple RCTs or at least 2 RCTs) is needed, where possible, to underscribe or
verify the statements. Evidence Based Guidelines can avoid improvisation,
which can lead to poor wound healing, bad health economics and needless pain
and suﬀering for the patient.
Only a few years ago, in our country, wounds were not routinely managed in a
holistic manner, and often now, we still see too much focus solely on the wound
instead of on the patient as a whole being. The principles of TIME, TIME-D,
TIME-H, Care cycle and WoundBedPreparation were a great step forward in
the right direction, but the aspect of a good diagnosis was still often neglected.
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The Evidence Based Guidelines are an excellent platform where nurses and
doctors can collaborate with each other as a multidisiplinary team. Guidelines
provide a tool, in which both doctors as nurses can follow a common pathway
to obtain wound healing.
We are convinced that this common method shall result in golden standards for
woundhealing, which in turn will lead to a higher level of quality in our daily work.
Nevertheless we must never forget that every patient is unique and that these
guidelines have a general character, not ﬁtting for each and every patient all of
the time. Therefore we must stay alert to the uniqueness of each patient and
avoid blindly following orders without looking at the clinical picture of the
whole patient.
Furthermore, Evidence Based Guidelines also provide a scaﬀold in our educa-
tional programs to doctors and nurses and we have to convince the health
workers to follow along in the same way of thinking and acting. CNC provides
educational programs in Belgium following the latest consensus and guidelines.
At this moment we can say: There’s still a lot of work to be done either by the
experts to develop further on more guidelines as by us in teaching our col-
leagues!
Who needs the lab on a chip for wound healing?
Raj Mani
Southampton University Hospitals Trust, Southampton, United Kingdom
The visibility of wounds and wound science has grown markedly over the last
20 years with the formation and publication of Cochrane reviews, dedicated
journals, publications and conferences. Various topics within this area are also
subjects of doctoral research programs. This enormous growth in communica-
tions has facilitated a serious clinical challenge that is posed by chronic wounds.
These communications have grown from very active hives where individuals
have dedicated their eﬀorts to improving diagnostic facilities, to understanding
tissue repair at cell and molecular levels and so on. All this activity notwith-
standing, clinically we continue to be dissatisﬁed with our abilities to manage
chronic wounds and its complications.
Infection and oedema are the most common of complications. Investigative
work up based on assessing perfusion, diabetic status etc will be more valuable
if we possessed the tools to assess these complications. The big question is will
one size ﬁt all?
Beyond evidence-based guidelines: cost-eﬀectiveness, impact on quality
of life and translation of guidelines into every day’s practice
Hilde Beele
Wound Care Center, Ghent University Hospital, Belgium
To ensure optimal wound care outcomes, clinicians must make wound man-
agement decisions based on systematically considered best practice informa-
tion. Therefore it is necessary to 1/ identify and 2/ disseminate cost-eﬀective,
well-tolerated, evidence based wound care interventions that improve patient
quality of life.
Just like in every ﬁeld of nursing and medicine, evidence based guidelines are
being developed in the ﬁeld of wound care. As the number of evaluable RCT’s
and meta-analyses remains quite low in this domain, systematic review of liter-
ature only provides limited levels of evidence. This is especially the case for re-
views concerning the clinical eﬃcacy of speciﬁc treatment modalities. Therefore
clinical guidelines on treatment of chronic wounds are not possible without the
endorsement of expert opinions and/or consensus panel recommendations.
It is generally accepted that chronic wounds can be very costly to the health care
system and can signiﬁcantly impair the quality of life of those who suﬀer from
them. On the other hand there are hardly any publications which have studied
the ﬁnacial implications of a certain therapeutic option, nor the eﬀect of a cer-
tain treatment on the quality of life. In a world where economical aspects and
the well-being of patients gain importance, the relative lack of this kind of ev-
idence makes it even more diﬃcult to give recommendation of how to chose
wound treatment strategies.
When evidence based treatment guidelines are compared with actual delivery of
wound care practice, important inconsistencies are observed. This could be due
to the fact that randomized controlled studies sometimes have a setup which is
quite diﬀerent from daily life practice. Clinical outcome studies and (local) clin-
ical databases could be very useful to ﬁll the gap between evidence based guide-
lines and daily practice in an objective way. Also studies to evaluate the best
methods for translating evidence based knowledge into multiple wound care
settings could be useful.
Collaborative working enhances wound care practice in tnp technology
Wojciech Witkowski, Bartlomiej Zon
Military Institute of Health Services, Plastic Reconstructive Surgery and Burn
Management Department, Warsaw, Poland
Introduction: As new TNP technologies emerge, it is important for clinicians to
form collaborative relationships with manufacturers, during the design and ﬁ-
nal phases of product development, with formal pre-launch clinical studies as-
sisting this process.
This research evaluated patients with a variety of complex wounds allocated a
new gauze based TNP device for wound care (WoundASSISTs TNP therapy
system, Huntleigh Technology Limited) with three primary objectives:
1. Report clinical outcomes for a range of complex and chronic wounds
2. Evaluate ease of use with the device, and dressing pack components
3. Gather patient and clinician user satisfaction
Methods: A multi-centre prospective clinical outcome study was conducted
across 3 specialist centres with varying levels of experience in using TNP; ‘nov-
ice’, ‘aware’, or ‘experienced’. Data collected; demographic, past & present
medical history, wound type, dimensions/progress and patient/clinician accept-
ability. Formal wound measurements and photography were conducted.
Results: 29 patients with chronic, complex or trauma wounds completed the
study.
 Mean wound surface area was 30.2 cm2 (1.9cm2–76.6 cm2) at the start of
treatment
 Average duration of therapy was 8.9 days 92–17 days)
Mean wound size reduction for all subjects was 23%
A consistent trend towards increased granulation tissue and epithelialisation
was observed. Patients found the therapy comfortable and acceptable whilst
clinicians reported a high level of satisfaction.
Conclusion: This study has shown positive and encouraging results in the treat-
ment and management of complex wounds. Eﬀective collaboration between
manufacturers and clinicians can lead to enhanced wound care practices
through the provision of products which promote practicality, ease of use and
evidenced based outcomes.
The end of the aﬀair: CXCR3 ligands stop wound repair and limit
scarring
Alan Wells1,2,3, Cecelia C. Yates1,2,3, Richard Bodnar1,2, Diana Whaley2,
Priya Krishna4
1Departments of Pathology and
4Otolaryngology,
2University of Pittsburgh and Pittsburgh VAMC,
3Pittsburgh, Tuskegee University Carver Research Foundation Tuskegee,
United States of America
The wound environment undergoes a series of changes that initially promotes
cellular dediﬀerentiation and cell repopulation of ﬁbroblasts, keratinocytes and
endothelial cells. However, late in the regenerative phase, the environment
switches to one that drives rediﬀerentiation of these cells and organ maturation.
Key regulatory signals that stop ﬁbroblast migration and induce the involution
of the excessive vascularization are the ELR-negative CXC chemokines
CXCL10/IP-10 and CXCL11/IP-9/I-TAC; these ligands bind to their common
G-protein coupled receptor (GPCR) CXCR3. Signaling through this receptor
stops ﬁbroblast immigration secondary to blockade of calpain2 activation and
rear release of locomoting cells, channeling these cells towards wound contrac-
tion. At the same time endothelial cell migration is similarly blocked but con-
comitant activation of calpain1 and subsequent integrin beta3 cleavage leads to
anoikis of nascent endothelial tubes reversing the exuberant angiogenesis of the
regenerative phase. Wounds in mice lacking CXCR3 do heal but the resulting
dermal tissue is hypercellular and hypervascular with pronounced cell turnover.
The skin presents diminished tensile strength due to the excessive collagen pre-
sented in thickened but disorganized ﬁbrils and persistent expression of
components of the immature wound bed such as tenascin-C, collagen VII and
ﬁbronectin. Furthermore, the epidermis does not receive signals to limit its pro-
liferation and by six months presents more layers of both nucleated and
enucleated cells. Thus, the picture emerges of a wound that, while closed,
refuses to stop healing, implicating the CXCR3 signaling system as key to
wound resolution.
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Fibroblasts are not equal in front of wound healing: new cell therapy
strategies
Bernard Coulomb
Inserm U849 Universite´ Paris-Descartes, Paris, France
Immediately after injury, several events occur to repair the damaged tissue.
Wound healing is a complex and dynamic process involving soluble mediators,
blood cells, extracellular matrix components and resident cells, in particular ﬁ-
broblasts. Brieﬂy, three interactive phases take place during the wound healing
process (inﬂammation, granulation tissue formation and remodeling). Thus,
the ‘‘quality’’ of the healing, i.e. disappearance of scar and recovery of tissue
functions, depends on a delicate equilibrium, and the remodeling phase, in
which ﬁbroblasts play a key role, is crucial for the rebuilding of the tissue as
close as possible with origin.
When the injured area is too large, grafting becomes necessary, but in very large
skin defects such as in burns, the amount of non-injured available skin is not
suﬃcient. Skin substitutes are then alternative solutions.
The minimum requirement is to re-establish a barrier function obtained by the
presence of the horny layer of the epidermis but there is a consensus as to the
necessity of a dermal component. Various dermal substitutes have been devel-
oped. Some are acellular matrices, while others combine ﬁbroblasts and extra-
cellular matrix components. The presence of living ﬁbroblasts has been shown
to promote the rapid emergence of a functional dermis and consequently to
permit eﬃcient epidermal anchoring. Interestingly, eﬃciency of healing in adult
depends on organs or tissues. Thus, the use of ﬁbroblasts from sources other
than the dermis is a promising approach in cell therapy strategies to tend to-
wards embryonic healing without scar and ﬁbrosis.
Cell-matrix interactions and scar formation.
Does the scar microenvironment sustain the scar status?
Magda Ulrich
Association of Dutch Burn Centres, Beverwijk, The Netherlands
The connective tissue plays an important role in tissue function, not only does it
serve as a scaﬀold to support the cells, but it also regulates cell function through
all kinds of growth factors and hormones which are stored within the extracel-
lular matrix (ECM). In addition the diﬀerent components of the ECM them-
selves inﬂuence cell function. The cells bind to diﬀerent molecules in the
extracellular matrix via integrins/integrin-receptors.
The (biochemical) composition of the ECM depends on the function of the tis-
sue and thus cells residing in the diﬀerent tissues expose diﬀerent phenotypes.
The cells depositing ECMmolecules, the ﬁbroblasts, are at least for a large part
responsible for their speciﬁc microenvironment. In normal skin, ﬁbroblasts are
surrounded by the ECM of the dermis and these cells posses a speciﬁc dermal
spindle shape phenotype. In third degree burn wounds the normal dermal mi-
croenvironment is completely destroyed. During healing of these wounds, cells
(including mesenchymal stem cells) are recruited from the surrounding tissues,
such as subcutaneous fat, and the circulation. Once arrived at the wound site
the cells start to repair the lost tissues and adept a phenotype promoted by the
micro-environment. Because the dermal environment is lacking the cells are
devoid of the proper control they acquire a phenotype of which the primary
function is to close the defect. The presence of abundant inﬂammatory media-
tors most likely has additional eﬀects on the transition into, for example, my-
oﬁbroblasts. The micro-environment created by these myoﬁbroblasts is
distinctly diﬀerent from normal dermal tissue and it is likely that unless inter-
ference takes place the cells will maintain this phenotype and deposit a defective
ECM. Excessive collagen deposition, an altered collagen type I to III ratio,
diﬀerent ﬁbril formation and altered crosslinking of collagen are only a few ex-
amples of diﬀerences in scar tissue in comparison with normal skin. It is very
likely that the diﬀerent microenvironment will maintain the ECM producing
cells in a scar phenotype. In order to improve wound healing therefore it is im-
portant to guide the cells to the correct phenotype through the creation of a
normal dermal microenvironment.
In vitro evaluation of a ﬁbroblast seeded Collagen /Elastin matrix
(Matriderm) – implication for in vivo use
H. Oliver Rennekampﬀ1, Weiguo Xu2, Sonja V Nolte2, H. Peter Rodemann2
1Division of Burn Medicine and Skin Regeneration, Medical School,
Hannover, Germany,
2Division of Radiobiology and Molecular Environmental Research, University
of Tubingen, Germany
The collagen/elastin matrix Matriderm was tested in vitro for potential use as a
vital skin equivalent. Therefore cell biological and immunohistological analysis
were performed to determine the potential of Matriderm to allow and promote
adherence, maturation and proliferation of keratinocytes and ﬁbroblasts. Fur-
thermore immunohistological analysis of basement membrane formation was
performed.
Human keratinocytes and ﬁbroblasts were established as primary cultures.
Speciﬁc diﬀerentiation states of ﬁbroblasts, mitotic progenitor type ﬁbroblast
(MF), or mitomycin –C induced post mitotic ﬁbrocytes (PMF) were used.
Adhesion rate of primary keratinocytes in acellular Matriderm was 68%. Fi-
broblasts adhered at about 73% after 10 hours of culture. Pre-seeding of Mat-
riderm with ﬁbroblasts enhanced keratinocyte take onMatriderm. Interestingly
pre seeding of the Matriderm inhibited keratinocyte migration deep into the
material.
Fibroblast seeded composites showed enhanced expression of keratinocyte
diﬀerentiation makers. The composite (keratinocyte -ﬁbroblast seeded Matrid-
erm) showed an enhanced basement formation (laminin and collagen IV ex-
pression) as compared to non-ﬁbroblast- seeded Matriderm. No clear beneﬁt
was observed in vitro when pre-seeding with MF: PMF in a 2:1 ratio as ob-
served in normal undiseased skin.In summary the ﬁbroblast-seeded collagen/
elastin matrix Matriderm exhibits enhanced capacity for keratinocyte promo-
tion and basement membrane formation. Seeding modalities for clinical use
have to be discussed.
Cross-linking aﬀects performance of collagen scaﬀolds in dermal repair
M. Vlig1, B. Boekema1, V.C. van der Veen1, L. OldeDamink3, I. Heschel3,
E. Middelkoop1,2 and M.M.W. Ulrich1,2
1Association of Dutch Burn Centres, Beverwijk, The Netherlands,
2Department of Plastic, Reconstructive and Hand Surgery, VU University
Medical Centre, Amsterdam, The Netherlands,
3Matricel GmbH, Herzogenrath, Germany
Introduction: Collagen scaﬀolds are increasingly used to treat full-thickness
wounds. Cross-linked as well as non cross-linked matrices are currently com-
mercially available. In this study, two commercially available scaﬀolds were
compared to 5 diﬀerent cross-linked and 5 diﬀerent non-cross-linked experi-
mental scaﬀolds in a porcine full-thickness surgical wound model.
Materials and Methods: Ten experimental scaﬀolds (NP1 till10) and two com-
mercially available scaﬀolds (a non-cross-linked (NX-L) and a cross-linked
control (X-L)) were transplanted, on full-thickness excisional wounds on the
ﬂanks of Yorkshire pigs. Subsequently a meshed split skin autograft (SSG) was
applied on top in the same procedure. Control wounds were transplanted with
the gold standard treatment; meshed SSG alone. Biopsies were taken on day 7,
14, 21 and 56.
Results: After 7 days the structure of all cross-linked scaﬀolds was clearly pres-
ent, where only remnants of the non-cross-linked scaﬀolds were visible. After 21
days, no remnants were found for both scaﬀold types. Giant cells were found
for both scaﬀold types. However, the cross-linked scaﬀolds showed much
higher numbers than the non-cross-linked. The cross-linked scaﬀolds showed
more contraction in comparison to SSG, but less contraction compared to X-L.
Three prototypes of the non-cross-linked experimental scaﬀolds showed less
contraction than the commercially available NX-L. Two of these closely ap-
proached the quality of healing seen for the SSG-standard.
Conclusion: When used for dermal wound repair, experimental cross-linked
scaﬀolds showed less contraction than the commercial X-L, but still lead to
wound contraction. The non-cross-linked scaﬀolds degraded fast, but with re-
spect to contraction, closely approached the gold standard treatment.
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Preliminary evaluation of a double-layered skin construct in a porcine
full-thickness wound model
Gerwen Lammers1, Vincent C. van der Veen2, Ronnie G. Wismans1, MagdaM.
Ulrich2, EstherMiddelkoop2,Willeke F. Daamen1 and Toin H. van Kuppevelt1
1Department of Biochemistry, Radboud University Nijmegen Medical Centre,
The Netherlands,
2Association of Dutch Burn Centres, Red Cross Hospital, Beverwijk, The
Netherlands
Introduction: To improve the healing of large wounds, a double-layered skin
construct (DLSC) was prepared, consisting of:
— 1. a porous scaﬀold of type I collagen and solubilised elastin, containing
dermatan sulfate and heparin, ﬁbroblast growth factor 2 and vascular endothe-
lial growth factor
— 2. a dense ﬁlm of type I collagen, containing heparin and FGF-7
In this study, the performance of the DLSC was evaluated in a porcine full-
thickness wound model and compared with the commercially available Integra
DRT and split-skin.
Materials and Methods: DLSCs (6x), Integra (6x) or split-skin (2x) were trans-
planted on full-thickness wounds (3 3 cm) on the back of two female York-
shire pigs. At day 7, the silicon layer of Integra was replaced by a split-skin, the
DLSC was not covered with split-skin.
Biopsies for H&E staining were taken on day 7, 14, 21 and 55.
Results and discussion: In the split-skin, a diﬀerentiated epidermis on a thin
dermis containing mainly ﬁbroblasts, newly formed extracellular matrix and
some blood vessels were found.
In the DLSC, newly-formed blood vessels and a major cellular response, con-
sisting of ﬁbroblasts, macrophages and neutrophils was observed, diminishing
from day 14 at places where the scaﬀold was degraded. From day 14, an epi-
dermis was formed, which may be due to the added FGF-7.
Integra showed, in comparison with the DLSC, a slower cellular response and
scaﬀold degradation. On day 7, mainly ﬁbroblasts and some blood vessels were
present, from day 14 accompanied by neutrophils, macrophages and the for-
mation of an epidermis.
Conclusion: Preliminary evaluation of the DLSC in a porcine full-thickness
wound model showed formation of an epithelium. In comparison to Integra, an
increased angiogenesis and cellular response at early time points was observed.
Raising standards in orthopaedic wound care – a prospective,
comparative evaluation of a modern dressing design
J.V. Clarke, J.M. Dillon, R.L. Sayer, I.P. McLean
Department of Orthopaedics, Dumfries &Galloway Royal Inﬁrmary, Bankend
Road, Dumfries, United Kingdom
Introduction: Prevention of infection in orthopaedics remains a constant chal-
lenge. In spite of increasing evidence to support use of modern dressings many
units use traditional adhesive dressings, which can cause wound healing prob-
lems. Our modern dressing design hydroﬁbre/hydrocolloid (HF/HC) was
highly eﬀective following hip and knee replacements in a national arthroplasty
unit. The aim of this study was to evaluate this dressing in a district hospital to
see if similar clinical outcomes could be achieved.
Methods: Prospective evaluation of the modern dressing involved 89 consecu-
tive elective and trauma patients from October 2007–January 2008. Outcome
measures included blistering, wear time, dressing changes, delayed discharge
and SSI rate. Results were compared to a traditional dressing currently used.
Results: 65 patients HF/HC group, 24 Traditional group. CUSUM tool set an
upper alert limit of 5% blister rate. Traditional group breached upper alert limit
after 8 cases. It was decided unethical to continue after 24 cases. Comparison of
HF/HC with Traditional showed blistering 1.5% versus 16.7%, wear time 4.8
versus 1.4 days and dressing changes 0.9 versus 2.8. Delayed discharge 0%
compared with 4.2%. SSI rates 0% versus 4.2%. All outcome diﬀerences were
statistically signiﬁcant except delayed discharge (po 0.05, Mann Whitney, chi-
square tests).
Conclusion: Implementation of evidence-based modern wound care into a dis-
trict general orthopaedic department achieved improved clinical outcomes with
elective and trauma patients, similar to those of a national arthroplasty unit.
This supports the use of the dressing and highlights the ongoing concerns of
traditional dressings used in orthopaedics.
Characterisation of bioﬁlms on epithelial surfaces by confocal
microscopy
David Williams
School of Dentistry, Cardiﬀ University, United Kingdom
Historically, microbiology research has tended to focus on single microbial
species cultured in liquid media. Such a ‘free living’ mode of growth is known as
the ‘planktonic’ growth phase and it is now recognised that such an existence is
rarely encountered in the general environment and clinical situations. A bioﬁlm
is deﬁned as a microbial community growing in a coaggregated form, often at-
tached to a solid substrata which may be abiotic or a living tissue, and encased
within an extracellular polymeric substance. The signiﬁcance of bioﬁlms is that
the organisms present can diﬀer greatly from their planktonic counterparts with
regards to resistance to environmental pressures such as those exerted by host
defence mechanisms and administered antimicrobials in clinical infections. As a
result it is now evident that bioﬁlms are implicated in over 65% of hospital ac-
quired infections. Furthermore, extensive physiological diﬀerences often man-
ifest as enhanced expression of virulence factors resulting in greater damage to
host tissue.
In order to combat bioﬁlms, research into their composition and structure is
required to identify the presence and interactions of signiﬁcant organisms. In
recent years, analysis of bioﬁlm structures has been greatly aided by the devel-
opment of new molecular biology techniques and imaging methods. In partic-
ular, the coupling of ﬂuorescent in situ hybridisation (FISH) with confocal laser
scanning microscopy (CLSM) has allowed the identiﬁcation and spatial loca-
tion of microorganisms with a 3D-image of bioﬁlms.
This presentation presents results of the in vitro production of two separate but
clinically important bioﬁlms involving Candida from the oral cavity, and also
chronic wound bacterial isolates. Through the use of CLSM and speciﬁc stain-
ing for respective organisms, strain and species variation in terms of bioﬁlm
construction will be demonstrated. Preliminary ﬁndings involving application
of these techniques to clinical specimens will also be shown. It is envisaged that
extrapolation of these approaches to clinical samples will allow bioﬁlm man-
agement techniques to develop by more targeted therapeutic measures.
A new antimicrobial enzyme system for the control of wound bioburden
K. De Smet, D. Van den Plas, D. Lens and P. Sollie
Flen Pharma NV, Research Department, Edegem (Antwerp), Belgium
Aim: A new, optimized, antimicrobial enzyme system was developed for the
control of wound bioburden. This Glucose oxidase – Lactoperoxidase – Gu-
aiacol (GLG) enzyme system, incorporated in an alginate gel dressing, was an-
alyzed for antimicrobial activity against antibiotic-resistant bacterial strains
and for cytotoxicity towards keratinocytes and ﬁbroblasts.
Methods: The susceptibility of a wide range of antibiotic-resistant bacterial
strains (clinical isolates) to the GLG enzyme system was analysed using Min-
imal Inhibitory Concentration (MIC90) determination. Further, challenge tests
and cytotoxicity tests were performed with Flaminals Forte, a new hydroactive
alginate gel dressing with antimicrobial activity, obtained by the presence of
1.5% GLG enzyme system.
Results: The MIC90- concentrations for most of the tested strains were in the
range of 0.015%–0.06% GLG enzyme system and for all Methicillin-Resistant
Staphylococcus aureus (MRSA) strains  0.004%. Challenge tests show that
for 11 strains all the bacterial cells are killed within 3 hours of incubation. For
the other 3 strains all the bacterial cells are killed within 6 hours of incubation.
Cytotoxicity determined by measuring metabolic activity using MTT assay on
cells incubated in a 20% Flaminals Forte solution showed no decrease in met-
abolic activity compared to the control cells. In contrast, other antimicrobial
wound care products showed a high degree of cytotoxicity.
Conclusion: With the increasing concern of bacterial resistance towards antibi-
otics, this study clearly shows that low concentrations of the GLG enzyme sys-
tem are successful in killing antibiotic-resistant bacterial strains. Furthermore,
results show that Flaminals Forte combines strong antimicrobial activity with
non-cytotoxicity, promoting optimal wound healing.
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Cadaveric donor skin: prediction for success of a split skin graft?
Sylvia A. Stegeman1,2, Caroline C. Naves1, Louk P. van Doorn2, Pascal
Steenvoorde1,2
1Department of Surgery, Rijnland Hospital Leiderdorp,
2Rijnland Wound Clinic, Rijnland Hospital Leiderdorp,The Netherlands
A split skin graft is usually only performed if the culture swab of the graft site is
negative. Unfortunately the graft site swab often shows bacterial growth. This
means that the split skin graft has to be postponed until the bacteria are no
longer present (for example after antibiotic therapy). The main disadvantage is
that the patient has to stay in the hospital for a much longer period of time. (It
can take weeks before the swab cultures are negative).
Our hypothesis is that bacterial growth will not determine whether a split skin
graft of cadaveric donor skin will be rejected immediately by the body.
Materials and Methods: Of all 17 patients included in this study, a culture swab
of the wound bed was taken. Then a split skin graft with human cadaver donor
skin was performed. If the donor skin was not rejected immediately, the patient
received an autologous split skin graft. However, if the donor graft was re-
jected, the patient was not grafted with an autologous graft. In the mean time if
the culture swab showed bacteria, antibiotics were prescribed.
Results: 13 patients received donor skin. None of these patients rejected the
donor skin. 4 patients were not treated with donor skin, since their wounds had
healed before the start of the treatment. After the donor skin treatment, all 13
patients received an autologous graft. In 12/13 patients (92.3%) the autologous
graft was received without any complications. This is the same success rate as
reported in the literature (90%).
However, the culture swabs showed that in most cases more than one bacteria
was present; most prominently Pseudomonas and the S. aureus. Only 2 patients
had a negative culture.
Conclusion: This study shows that donor skin grafting can predict if an auto-
logous split skin graft will be a success, even if the wound has bacterial growth.
This could mean that it is not necessary to delay split skin grafting in order to
remove bacteria.
Characterisation of bioﬁlms within medical devices
S.A. Cairns1, D.W. Williams1, J. Thomas2, S. Hooper1, M. Wise3, P. Frost3,
S. Malic1, M. Lewis1, K.G. Harding1, D.J. Leaper1
1Cardiﬀ University, United Kingdom,
2West Virginia University, Morgantown, USA,
3University Hospital of Wales, Cardiﬀ, United Kingdom
Introduction: The concept of bacteria as a solely planktonic life form is rapidly
becoming outdated. In actuality, the planktonic phenotype, seems to merely
represent a phase in the life cycle of bacterial colonies, with permanent adherent
microcolonies called Bioﬁlms, representing the ‘‘natural’’ state of many species.
Bioﬁlm presence has long been recognised in water treatment facilities and in
dental plaque.
More recently bioﬁlms have been identiﬁed on many medical devices including,
contact lenses, breast implants, hip prostheses and venous cannulas.
Colonisation of endotracheal tubes (ETTs) with bacterial ﬂora is thought to be
a source of recurrent ventilator associated pneumonia and as a medical device
in contact with known bioﬁlm-forming dental ﬂora; ETTs represent an ideal
environment to investigate bioﬁlm micro-diversity.
Objectives: The aim of this work was to identify the presence of bioﬁlms with
endotracheal lumens, and to characterise the microﬂora therein.
Methods: 26 ETTs were obtained from 21 patients in a General ICU. Sampling
involved the physical removal of bioﬁlms within the airway lumens and from
the dressings. Bacterial cell culture techniques were used to quantify and iden-
tify microorganism populations present. Colonies were further characterised
using molecular methods such as Denaturing Gel Gradient Electrophoresis
(DGGE) and PCR. Confocal Light Scanning Microscopy (CLSM) was used to
elucidate the three dimensional nature of the bioﬁlms.
Results: Molecular analysis shows multiple bacterial genotypes within each
endotracheal tube, and consisting of a range of microorganisms including den-
tal ﬂora, such as Streptococcus mutans and Pseudomonas gingivalis, as well as
recognised pathogens like Pseudomonas aeruginosa. Bacterial culture methods
similarly identify many cohabiting phenotypes, and using cultural assays,
counts of up to 210 million colony forming units within each centimetre length
of the ETTs. Cultural and structural analysis revealed the presence of fungal
hyphae adding to the bioﬁlm, identiﬁed as Candida albicans.
Conclusion: Endo tracheal tubes have been shown to harbour polymicrobial
bioﬁlms, consisting of dental ﬂora and pneumonia-causing pathogens. This has
important consequences for intubated patients, and the role of a non-adherent
or bactericidal coating in ETTs needs to be evaluated. These techniques will
now be applied to tracheostomies and burn wounds.
Analysis of extracellular matrix proteins during wound healing
processes
Manuel Koch
Center for Biochemistry, Department of Dermatology, and Center for
Molecular Medicine, University of Cologne, Germany
During wound healing, the extracellular matrix has to be remodelled. Espe-
cially, to obtain the mechanical stability of the scare tissue, collagens have to be
deposited. Collagens are a rather heterogenic group of molecules, deﬁned by
their Gly-X-Y repeats. In addition to the ﬁbril forming collagens, other colla-
gens termed FACIT collagens, are ﬁbril associated collagens with interrupted
triple helices. Two members of this family, collagen XII and XIV are expressed
in skin. The domain structure of collagen XII and XIV consist of two small C-
terminal interrupted collagenous domains and a large non-collagenous NC3
domain that comprises 90% of the protein mass. FACIT collagens are thought
to function as a modulator of ﬁbril formation and/or as a bridging molecule
between the ﬁbrils and the surrounding extracellular matrix. In this study, we
investigated the localization of these proteins in adult skin, during skin devel-
opment, and in healing and non-healing wounds, e.g. in adult mice skin, colla-
gen XII is deposited close to the basement membrane around the hair follicle.
To further study the function of collagen XII in vivo, a collagen XII knockout
mouse line was generated and the skin phenotype was analyzed.
The placenta growth factor in wound repair
T. Odorisio, F. Cianfarani, C.M. Failla and G. Zambruno
Laboratory of Molecular and Cell Biology, IDI-IRCCS, Rome, Italy
Cutaneous wound healing is strictly dependent on an eﬃcient angiogenic re-
sponse and vascular defects often underlie impaired repair and chronic ulcer
formation. Improving the angiogenic response has been, therefore, considered
as a therapeutic approach in ulcer treatment. Placenta growth factor (PlGF), a
member of the vascular endothelial growth factor (VEGF) family acting
through the VEGFR-1 receptor, is expressed during the angiogenic phase of
wound healing. The analysis of PlGF knockout mice has revealed that in the
absence of this factor granulation tissue vascularization is reduced and the
healing process retarded. With respect to VEGF, PlGF displays weaker pro-
angiogenic activity, but the capacity to induce non leaky, mature vessel forma-
tion, without compromising lymphatic functionality makes it a promising
therapeutic tool. In diabetic wounds, PlGF expression is strongly reduced, and
local PlGF overexpression accelerates diabetic wound closure by enhancing
granulation tissue vascularization. Moreover, diabetic wound treatment with
an adenovirus vector carrying the PlGF gene (Ad.PlGF) accelerates wound
healing by improving granulation tissue formation and vascularization. A key
eﬀect of PlGF activity resides in its ability to chemoattract VEGFR-1 express-
ing cells. Adenovirus-mediated PlGF gene transfer associates with increased
local macrophage recruitment, while VEGFR-11 hematopoietic stem cell mo-
bilization into the peripheral blood is not enhanced due also to progenitor cell
lack of responsiveness to PlGF in the diabetic condition. Cultured normal der-
mal ﬁbroblasts also express VEGFR-1 and PlGF treatment promotes their
function by improving motility and the capacity to invade matrigel. Moreover,
PlGF recovers migration impairment of diabetic cultured ﬁbroblasts. Such
ﬁndings reveal a possible direct eﬀect of transduced PlGF in inducing granula-
tion tissue formation in diabetic wounds. The analysis of the eﬀect of PlGF ad-
ministration to diabetic wounds shows that this factor has therapeutic potential
for ulcer treatment by potentiating diﬀerent aspects of the repair process.
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The impact of proteases on wound angiogenesis
Daniel Hoﬀmann1, Manuel Koch1,2, Thomas Krieg1, Sabine Eming1
1Department of Dermatology,
2Center for Biochemistry, Medical Faculty, University of Cologne, Cologne,
Germany
VEGF family members are key mediators in vascular remodeling. Structure-
function analysis of these protein families is not complete and a detailed anal-
ysis is mandatory for a comprehensive understanding of this essential growth
factor family in processes such as tissue repair and tumor development. A com-
mon structural feature of VEGF proteins is diﬀerential mRNA splicing of a
single gene, which gives raise to diﬀerent protein isoforms that diﬀer primarily
in the absence or presence of a carboxyl-terminal domain of highly basic-amino
acids. This so called heparin-binding domain (HBD) has been identiﬁed as the
epitope for the cell surface glycoprotein neuropilin and proteoglycans, both of
which are central receptor molecules to control vascular growth. However, it is
still unclear how cell functions are speciﬁcally modulated by neuropilin/pro-
teoglycan and HBD interactions of diﬀerent VEGF protein members. We per-
formed systematic structure-function analysis of diﬀerent proteins of the
VEGF family which will be discussed.
Systemic transplantation of progenitor cells accelerates wound
epithelialization and neovascularization in the hairless mouse ear wound
model
Anna Lena Sander1, Heike Jakob1, Dirk Henrich1, Maciej Powerski1, Stefanie
Dimmeler2, John Barker3, Johannes Frank1, Ingo Marzi1
1Department of Trauma, Hand and Reconstructive Surgery, Hospital of the
Johann Wolfgang Goethe-University, Frankfurt/Main, Germany,
2Molecular Cardiology, Department of Internal Medicine IV, Hospital of the
Johann Wolfgang Goethe-University, Frankfurt/Main, Germany,
3Division of Plastic and Reconstructive Surgery, Department of Surgery,
University of Louisville, Kentucky, USA
Impaired wound healing is a major clinical problem. Recent, studies have
shown that endothelial progenitor cells (EPC), from the peripheral blood, ac-
cumulate in granulation tissue at the site of neovascularization causing secre-
tion of growth factors and cytokines. To investigate these ﬁndings, we
transplanted systemic EPC and then measured epithelialization and neovascu-
larization in the hairless mouse ear wound model.
Standardized full thickness dermal wounds (2.25mm diameter) were created on
the dorsum of the mouse ear. Wound epithelialization was measured every third
day until wounds were completely healed, using intravital microscopy and
computerized planimetry. CD31, CD90, cytokine stromal cell-derived factor 1a
(SDF1a) and vascular endothelial growth factor (VEGF) were measured on
days 3 and 6 using immunohistochemistry.
The systemic transplantation of heterogeneous EPC had a high signiﬁcant
(po .0001) eﬀect on wound healing with resurfacing occurring by 6.5 day-
s 0.12 days compared with that after PBS injection by 10.5 days 0.32 days.
Immunohistochemically, the EPC-transplanted group showed a signiﬁcant in-
crease in vascular density relative to the PBS-treated group indicated by CD31
staining (15.03mm2 2.44mm2 vs. 6.72mm2 0.85mm2 at day 6; po .001).
Furthermore, the transplantation of EPC increased the expression of the
SDF1a (5.1 1.69 vs. 1.05 0.26 at day 3, po .01; 11.83 3.86 vs. 1.8 0.35
at day 6, po .001; 18.34 3.55 vs. 2.97 0.59 at day 12, po .001).
These ﬁndings demonstrate that transplanting systemic EPC into ‘‘normal’’
healing wounds promotes epithelialization and neovascularization and thus
could be a useful method for accelerating wound healing.
Identifying a Gene signature for the wound healing continuum
Peake, M.A., Giles, P.J., Wall, I.B., Enoch, S., Kipling, D., Thomas, D.W.,
Stephens, P.
Wound Biology Group, Tissue Engineering and Reparative Dentistry, School
of Dentistry, Cardiﬀ University
Introduction: There is a deleterious eﬀect upon wound healing functionality as-
sociated with increasing age with a continuum between old and young. Oral
mucosal ﬁbroblasts (OMFs) display rapid, scarless, wound healing and repre-
sent a young ‘enhanced’ wound healing phenotype. At the other extreme, ‘aged’
chronic wound ﬁbroblasts (CWFs) display an impaired wound healing pheno-
type. Between these extremes lie normal dermal ﬁbroblasts (NDFs) which have
an intermediate healing phenotype.
Aim: To identify a signature group of genes whose pattern of expression cor-
relates to the wound healing continuum.
Methods/Results: Primary OMFs and CWFs were compared to patient
matched NDFs (n=3 and n=4 respectively). Early passage cultures were ‘se-
rum starved’ for 48 hours and re-stimulated with serum, modelling an in vivo
wound response. RNA isolated 0 and 6 hours after serum stimulation was
analysed by AﬀymetrixTM cDNAMicroarray.
Comparison of serum modulated genes in OMFs, NDFs and CWFs to ascend-
ing/descending continuum patterns identiﬁed 221 genes with continuum-like
expression characteristics including genes which were serum induced or re-
pressed to descending or ascending levels across the sampled continuum. For
example, BMP2 expression displayed high levels of serum induction in OMFs
(684), which was reduced in NDFs (350/197) and further reduced in CWFs (71).
Conclusion: This analysis demonstrated that there are a number of genes dis-
playing a continuum-like pattern of expression and may help in the identiﬁca-
tion of gene expression signatures for wound healing.
Lympho-hematopoietic stem cells and their ageing
Hartmut Geiger
Division of Experimental Hematology, Cincinnati Children’s Hospital Medical
Center, Cincinnati, United States of America
The lympho-hematopoietic system is largely composed of cells with short life-
spans (days) and thus requires continuous replenishment of the cells lost
through hematopoietic stem and progenitor cells in a process called hemato-
poiesis. Experimental evidence from several laboratories clearly demonstrates
that hematopoietic stem cells harvested from young and aged animals show
functional diﬀerences that are intrinsic to hematopoietic stem cells, implying
that also stem cells in the hematopoietic system can not defy aging. We will thus
discuss the cellular phenotypes and the possible molecular mechanisms associ-
ated with aged hematopoietic stem cells with respect to the speciﬁc properties
stem cells are endowed with, and will investigate whether stem cell aging is in-
evitable or whether some of its aspects can be reverted or at least ameliorated.
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The ROS connection in ageing and tissue repair
Karin Scharﬀetter-Kochanek, Anca Sindrilaru and Meinhard Wlaschek
Department of Dermatology and Allergic Diseases, University of Ulm,
Germany
Chronic venous leg ulcers represent the ﬁnal outcome of lower extremity
chronic venous insuﬃciency in many patients. Chronic ulcers of the lower leg
have a prevalence of 3 to 5% in the population over 65 years of age with an
increase of up to 12% in the population over 70 years of age. The incidence of
ulceration is rising as a result of our ageing population. As healing may be slow
or may never be achieved, ulcers create persistent and substantial demands on
resources. Since the ageing trend of the world’s population is unbroken and the
prevalence of chronic venous diseases is correlated with age, it can be predicted
that the ﬁnancial load of the society for the treatment will increase in future.
Great eﬀorts have been made to accelerate tissue repair in chronic venous leg
ulcers with only limited success. This may at least be partly due to the ﬁnite
knowledge of the pathophysiology of chronic wounds and the role of their mi-
croenvironments. Factors that play a role in impaired wound healing, in addi-
tion to local and systemic factors like venous insuﬃciency, ischaemia and
malnutrition, are an increase in the concentration of reactive oxygen species
(ROS) due to persistent macrophage activation, increased proteolysis with a
decrease in concentrations of growth factors, and the presence of senescent cells
in the tissue of the ulcer base and edge. The exact underlying mechanisms driv-
ing chronically impaired wound healing are still unknown. An emerging se-
quence of events with toxic concentrations of reactive oxygen species has been
identiﬁed, in conjunction with increased free iron and a hostile proteolytic mi-
croenvironment being the key events of tissue destruction and localized prema-
ture ageing in chronic venous leg ulcers. Based on these data, a therapeutic
algorithm has been established.
Cellular senescence and tissue homeostasis
Dimitris Kletsas
Laboratory of Cell Proliferation & Ageing, Institute of Biology, National
Centre for Scientiﬁc Research ‘‘Demokritos’’, Athens
Normal cells can undergo only a limited number of doublings and then became
permanently growth arrested. This, so-called replicative senescence, is a conse-
quence of a progressive telomere shortening that is perceived by the cells as a
DNA damage leading to the activation of p53 tumor suppressor and thus to cell
cycle arrest. In addition, the cells can senesce prematurely after exposure to
various types of stress. Interestingly, the overexpression of several oncogenes
leads also to premature senescence, indicating that senescence represents a po-
tent anticancer mechanism. We have shown that this stress-induced senescence
is due to a DNA damage response, suggesting common mechanisms underlying
the various types of cellular senescence. Beyond their inability to proliferate,
senescent cells express a pro-inﬂammatory phenotype, implying that they are
locked in an activated state mimicking the early remodeling phase of wound
repair. It is believed that due to this phenotype senescent cells can contribute to
the ageing process and to the development of various pathologies, including
implications in wound repair. We have shown that p53 is responsible for the
senescence-associated overexpression of inﬂammatory molecules such as
ICAM-1, indicating that the various features of senescence (cell cycle arrest
and the pro-inﬂammatory phenotype) are, at least in part, linked with the same
molecular mechanisms. In addition, although senescence is considered to be an
anticancer barrier, it has been proposed that senescent cells, due to their speciﬁc
inﬂammatory phenotype, create a permissive environment for the growth of
cancer cells. In this vein we have shown that senescent stromal lung ﬁbroblasts
enhance the growth of cancer cells, both in vitro and in vivo, supporting the
idea that the role of senescence in tissue homeostasis is antagonistically pleio-
tropic.
Ageing in clinically relevant settings of tissue repair
Lisa Gould
Department of Surgery, James A. Haley Veterans Hospital, University of
South Florida, Tampa, United States of America
By the year 2050, one in ﬁve Americans will be over the age of 80, an increase
from 12% in the year 2000. Although people are living longer, many have
chronic diseases and many more will be diagnosed with conditions that require
surgical treatment. Although current literature suggests that acute wound heal-
ing is not impaired by age alone, elderly patients are more susceptible to peri-
operative complications that can impede wound healing. Malnutrition, a major
risk factor for the development of non-healing wounds, has been reported to be
present in 61% of elderly patients in the perioperative period. This high com-
plication rate may be due to aberrations in the stress response that occur with
aging. The majority of chronic wounds occur in older adults with multiple co-
morbidities. Contributing factors include impaired scavenging of reactive oxy-
gen species, increased expression of cellular inﬂammatory factors, reduced
inﬂammatory cell function and impaired angiogenesis. Alterations in the heal-
ing response due to age alone may not be suﬃcient to prevent healing, but the
additional stress of chronic diseases such as diabetes and peripheral vascular
disease tips the balance to a state of ‘acute on chronic’ oxidative stress.
We have used a rat model to evaluate the eﬀect of age and ischemia on wound
healing. In this model we have demonstrated that ischemia impairs wound
healing in aged rats more than young. Despite elevated superoxide dismutase
activity, ischemic wounds of the aged rats had markedly elevated levels of 3-
nitrotyrosine. Our hypothesis is that there is a relative deﬁcit of glutathione re-
sulting in the inability to convert hydrogen peroxide to water. Further elucida-
tion of this mechanism will lead to therapies that improve wound healing in the
elderly.
An in vitro fetal wound model
N.A. Coolen1,2, C.W.M. Schouten1, V.C. van der Veen1, E. Middelkoop1,2 and
M.M.W. Ulrich1,2
1Association of Dutch Burn Centres, Beverwijk, The Netherlands,
2Department of Plastic, Reconstructive and Hand Surgery, VU University
Medical Centre, Amsterdam, The Netherlands
Introduction: Early gestation fetal wounds heal without scar formation. Un-
derstanding the mechanism of this scarless healing may lead to new therapeutic
strategies for improving adult wound healing. The aim of this study is to de-
velop a human wound model in which scarless wound healing can be studied.
Methods andMaterials: Aburn wound (10 2mm) was made in human ex vivo
fetal skin and in ex vivo adult skin under controlled and standardized condi-
tions. Subsequently, the skin samples were cultured at the air-liquid interface
for 7, 14, and 21 days.
Results: During culture, re-epithelialization of the wound took place in both
the fetal and adult skin samples. However, the neo-epidermis covered a higher
percentage of the burn wound in fetal skin. Incubation with bromodeoxyuri-
dine showed that cells of the epithelial tongue and ﬁbroblasts in the wound area
were proliferating. More proliferating cells were present in fetal skin than in
adult skin. Similar to in vivo early gestation wound healing, a-smooth muscle
actin was observed only in the blood vessels and not in the ﬁbroblasts.
Discussion: This in vitro fetal skin model can be used to examine diﬀerent as-
pects of scarless wound healing. The model contains all cell types normally
present in human fetal skin and can easily be studied. Our model can be ma-
nipulated to study the role of certain growth factors or other elements in scar
formation.
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A search for embryonic eﬀector molecules for a skin construct by exon
array analysis of developing skin
P.J.E. Uijtdewilligen1, C.F.H.A. Gilissen2, S.V. van Reijmersdal2,
W.F. Daamen1 and T.H. van Kuppevelt1
1Dept. of Biochemistry, NCMLS, Radboud University Nijmegen Medical
Centre, Nijmegen, The Netherlands,
2Dept. of Human Genetics, Radboud University Nijmegen Medical Centre,
Nijmegen, The Netherlands
Introduction: The current treatments of skin lesions do not result in full skin
regeneration. To get closer to true regeneration of damaged skin, one approach
may be to release those growth factors/morphogens that are involved in em-
bryonic development, thus mimicking embryonic skin generation. A ﬁrst step in
this approach is to identify appropriate eﬀector molecules. Using microarray
analysis, we have selected two growth factors/morphogens essential for embry-
onic skin development. In future studies, these eﬀector molecules will be incor-
porated in a collagen-glycosaminoglycan construct for sustained release and
evaluated for their potential to induce skin regeneration.
Materials and Methods: Using mice, four time points were selected: E14, E16,
P1 and P90. RNA was isolated from dorsal-lateral skin. The expression levels
were analyzed using Aﬀymetrix GeneChip Mouse Exon 1.0ST Arrays. The ob-
tained data set was screened using three selection criteria: 1) the eﬀector mol-
ecule must have growth factor and/or morphogenic properties; 2) the eﬀector
molecule must show embryonic speciﬁc expression; 3) the eﬀector molecule
must be able to bind to glycosaminoglycans. The gene expression levels of the
candidate genes found with the exon array were validated by Real Time-Quan-
titative PCR.
Results and discussion: Based on these criteria, we found several candidate
genes of which insulin-like growth factor 2 (IGF2) and sonic hedgehog (SHH)
are most promising. IGF2 expression was found at E14, E16 and P1, but not at
P90. IGF2 stimulates cell proliferation in both epidermis and dermis and may
additionally stimulate angiogenesis via increased VEGF expression. SHH ex-
pression was found predominantly at E16 and P1, supporting the observation
that SHH may stimulate appendage formation. Both molecules can be incor-
porated in collagenous scaﬀolds via the glycosaminoglycan heparin.
Myoﬁbroblasts in the liver: ﬁbrosis, cirrhosis and the stromal reaction to
liver cancers
Alexis Desmoulie`re
University of Limoges, France
Fibrosis, deﬁned as the excessive deposition of extracellular matrix in an organ,
is the main complication of chronic liver damage. Its endpoint is cirrhosis,
which is responsible for signiﬁcant morbidity and mortality. The accumulation
of extracellular matrix observed in ﬁbrosis and cirrhosis is due to the activation
of ﬁbroblasts, which acquire a myoﬁbroblastic phenotype. Myoﬁbroblasts are
absent from normal liver. They are produced by the activation of precursor
cells, such as hepatic stellate cells and portal ﬁbroblasts. These ﬁbrogenic cells
are distributed diﬀerently in the hepatic lobule: the hepatic stellate cells resem-
ble pericytes and are located along the sinusoids, whereas the portal ﬁbroblasts
are embedded in the portal tract connective tissue around portal structures.
Diﬀerences have been reported between these two ﬁbrogenic cell populations,
in the mechanisms leading to myoﬁbroblastic diﬀerentiation, activation and
‘‘deactivation’’, but conﬁrmation is required. It is now widely accepted that the
various types of lesion (e.g., lesions caused by alcohol abuse and viral hepatitis)
leading to liver ﬁbrosis involve speciﬁc ﬁbrogenic cell subpopulations. The bi-
ological and biochemical characterisation of these cells is thus essential if we are
to understand the mechanisms underlying the progressive development of ex-
cessive scarring in the liver. Moreover, in liver cancers, the myoﬁbroblast is the
main cell involved in the formation of the tumoral stroma. Usually, in hepato-
cellular carcinoma, tumoral stroma is scanty; often, the tumoral stroma is
mixed with the ﬁbrous stroma of the surrounding cirrhosis. In contrast, in
cholangiocarcinoma, the stroma is abundant, sclerous, sometimes with calciﬁ-
cation and may be extensive. We can assume that, in these two types of cancers,
the myoﬁbroblasts involved in the stroma derived from diﬀerent subpopula-
tions of liver ﬁbroblasts. All this information is required for the development of
treatments speciﬁcally and eﬃciently targeting the cells responsible for the de-
velopment of ﬁbrosis/cirrhosis, and of tumoral stroma.
The myoﬁbroblast – friend or foe in regenerative medicine?
Boris Hinz
Laboratory of Cell Biophysics, Ecole Polytechnique Federale de Lausanne
(EPFL), CH-1015 Lausanne, Switzerland
Excessive myoﬁbroblast contraction impairs tissue function as in hypertrophic
scars, in ﬁbrotic diseases, and in the stroma reaction to epithelial tumors.
Moreover, bioengineering approaches must prevent myoﬁbroblast formation,
either arising from mesenchymal stem cells that are used to repair tissues/or-
gans of mesodermal origin or from ﬁbroblasts at the interface between implant
and host tissue. The contractile apparatus of myoﬁbroblasts represents an im-
portant therapeutic target to reduce ﬁbrosis and to increase bioengineering suc-
cess rates.
Myoﬁbroblasts not only exert force but adapt to the stress in their microenvi-
ronment. I will present various strategies to modulate myoﬁbroblast tension,
such as innovative polymer materials of diﬀerent stiﬀness and control over cell
size and adhesion by surface microstructuring. As a general rule, releasing my-
oﬁbroblasts from stress leads to the loss of contractile features and ultimately to
de-diﬀerentiation and/or apoptosis. We propose therapeutically interfering
with their stress-perception apparatus as novel strategy to eliminate ﬁbrogenic
cells.
Alpha – smooth muscle actin (aSMA) expression in foetal skin
ﬁbroblasts
V.C. van der Veen1, N.A. Coolen1,2, E. Middelkoop1,2 and M.M.W. Ulrich1,2
1Association of Dutch Burn Centres, Beverwijk, The Netherlands,
2Department of Plastic, Reconstructive and Hand Surgery, VU University
Medical Centre, Amsterdam, The Netherlands
Introduction: Early to mid-term foetuses heal deep skin wounds without the
formation of a scar. Determination of the diﬀerences between adult and foetal
wound healing might yield insights about how we could achieve scar-less heal-
ing in adult skin. The goal of this study is to investigate the behaviour of foetal
and adult skin ﬁbroblasts in dermal matrices.
Material and Methods: Foetal and adult skin ﬁbroblasts were cultured on glass
slides, Matriderm, Integra and De-Epidermised Dermis (DED). Cells on glass
slides were ﬁxed in formalin upon conﬂuence. The dermal matrices were cul-
tured for three weeks and contraction was determined using planimetry. The
matrices were ﬁxed and aSMA expression was assessed with immunohisto-
chemistry.
Results: Foetal skin ﬁbroblasts were able to contract Matriderm scaﬀolds while
Integra and DED did not show any signiﬁcant contraction. Histological anal-
ysis showed strong aSMA expression in ﬁbroblasts cultured on glass and in
Matriderm, while in DED and Integra almost no aSMA expressing cells were
found.
Discussion: Foetal skin ﬁbroblasts appear to be able to contract certain matri-
ces and express high amounts of aSMA when cultured on glass or an artiﬁcial
collagen matrix. This indicates that the absence of aSMA activity in foetal
wounds is not an intrinsic property of these cells but rather is caused by the
cell’s surroundings. Interestingly the glycosaminoglycan containing scaﬀold
showed reduced contraction and aSMA expression. Whether this is due to the
glycosaminoglycan needs to be studied further.
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Controlled mechanical stimulation of skin cell proliferation in vivo
Giorgio Pietramaggiori1,3, Saja S. Scherer2,3, Luca Lancerotto4, Ali
Modaressi1, Dennis P. Orgill3, Boris Hinz5, and Brigitte Pittet1
1Division of Plastic Surgery, University of Geneva, Switzerland,
2Division of Plastic and Reconstructive Surgery, BG-Unfallklinik
Ludwigshafen, University of Heidelberg, Germany,
3Division of Plastic Surgery, Brigham and Women’s Hospital, Harvard
Medical School, Boston, MA,
4Division of Plastic Surgery, University of Padua, Italy,
5Laboratory of Cell Biophysics, Ecole Polytechnique Federale De Lausanne
(EPFL), Switzerland
Introduction: Cells respond to mechanical cues from the environment by in-
creased proliferation and matrix organization. Although physical devices are
currently used in clinics, the forces applied are empirically decided and scientiﬁc
results have not been recollected. In this study, a custom designed stretch device
was used to systematically investigate the role of mechanical stimulation in
vivo.
Methods: A stretch device was applied on the intact (n=18) or wounded
(n=10) skin of mice. Using this device, the skin received 0.5N continuous or
0.5N cyclical (2min on/1min oﬀ) stretching forces for 1 or 4 hours. Sham de-
vices were used as controls. After 2 and 10 days, skin was harvested for
immunolocalization of cell proliferation (Ki-67), vascularity (PECAM-1), and
inﬂammation (CD45).
Results: Both continuous and cyclical forces stimulated cell proliferation, with
cyclical patterns being the fastest triggers. The vascular area and perfusion of
stretched tissues increased in parallel. Ten days post stretch, when signs of ex-
tracellular matrix reorganization started to appear, cell proliferation returned
to baseline. Wounds receiving cyclical stimulation showed maximal histological
response.
Conclusion: In light of the disappointing results obtained with growth factors,
physical stimulation appears to be a promising strategy to stimulate wound
healing. The proliferative response to mechanical stimulation of epidermal cells
was higher compared to cells in the dermis, a mechanically shielded environ-
ment. Cyclical force regimens appeared to be more eﬀective in both intact tis-
sues and wounds.
The role of avb6 integrin in diabetic wound healing in mice
J. N. Jacobsen1,2, C. Xie1, K. A. Krogfelt2, H. S. Larjava1
1Department of Oral Biology and Medical Sciences, Faculty of Dentistry,
University of British Columbia, Vancouver BC, Canada
2Statens Serum Institut, Copenhagen, Denmark
Introduction: Integrins are cell-speciﬁc heterodimeric receptors that bind to ex-
tra cellular matrix components, thereby stimulating intracellular signaling
pathways necessary for cell proliferation, diﬀerentiation, and migration. Dur-
ing wound healing, expression of avb6 integrin is induced by keratinocytes. In
the present study, we compared wound healing rates between b6 integrin-deﬁ-
cient (b6 / ) mice and wild type (WT) under normal conditions, and in ani-
mals challenged with streptozotocin (STZ)-induced diabetes.
Methods: Twenty 12-months-old male FVB mice were enrolled in this study.
Half of the animals were made diabetic using daily i.p. injections of citrate-
buﬀered STZ (55mg/kg) for six consecutive days. Control animals were in-
jected with citrate-buﬀer only. After ﬁve weeks, four full-thickness 4mm exci-
sional wounds were created on the dorsal skin of each mouse. Wound healing
rates were quantiﬁed by measuring wound areas over 10 days using NIH Im-
ageJ analysis software (http://rsb.info.nih.gov/ij/).
Results: No signiﬁcant diﬀerence in wound healing rates between WT and
b6 / control mice was observed, and these wounds all closed at day 9. In
general, diabetes-induction yielded a 3 day healing delay for bothWT and b6 /
 compared to controls. Within the diabetic group, a signiﬁcant delay in day
1–3 (po 0.05, Student’s t-test) and day 4–5 (po 0.01) was observed in the b6 /
 mice compared to WT.
Conclusion: The avb6 integrin does not aﬀect wound healing rates under nor-
mal conditions. However, when challenged with diabetes, avb6 integrin deple-
tion results in a dramatic delay in wound healing. This ﬁnding might gain novel
insight into the molecular pathophysiology of impaired diabetic wound healing.
Bioengineered tendon: from tenocytes culture to ASCs (Adipose
Derived Stem Cells) culture
Bassetto Franco1, Vindigni Vincenzo1, Dalla Vedova Alessandro1, Carolin
Tonello2, Giovanni Abatangelo2
1Division of Plastic Surgery, University of Padua, Italy,
2Department of Histology, Microbiology and Medical Biotechnologies,
University of Padua, Italy
Background: After a tendon injury, the healing process results in formation of a
ﬁbrotic scar. The structural organization and mechanical properties of this
healed tissue are insuﬃcient since tendon has a limited regeneration capacity.
This is the reason why obtaining tendinous tissue by means of tissue engineering
becomes a clinical necessity. Recently medical research stressed the importance
of ASCs which can diﬀerentiate in vitro toward the osteogenic, adipogenic,
myogenic, and chondrogenic lineages.
Objective: The aim of the present study is the reconstruction of a tendon struc-
ture using ASCs undergone mechanical stress.
Methods: ASCs were isolated from lipoaspirate, expanded to obtain an ade-
quate cellular density and placed on the biomaterial of hyaluronic acid
(HYALONECTs). Utilizing an experimental bioreactor, traction conditions
were maintained. Samples were analyzed with histological studies, immunohis-
tochemical studies and electron microscopy analysis. Speciﬁc gene expression
was studied with RT-PCR.
Results: After 18 days of culture, cells were found adhering to the ﬁbres of the
scaﬀold and synthesis of the extracellular matrix was observed. The application
of mechanical stress allowed the alignment of cells and the extracellular matrix,
parallel to the traction lines. RT-PCR showed maintenance of the diﬀerentiated
phenotype.
Discussion and conclusion: Taking our stand on these observations, we can
conclude that ASCs cultivated in dynamic conditions on a three-dimensional
support made up of hyaluronic acid, are able to reconstruct a tendon tissue.
Thus we can hypothesize that ASCs are able to diﬀerentiate and organize them-
selves in tendon structures, opening therefore new surgical prospects for ther-
apy of tendon injuries.
ANOSF (Nano-Oligosaccharide Factor) lipido-colloid dressing inhibits
MMPs in an in vitro dermal equivalent model
Bernard Coulomb1, Ludovic Couty1, Benjamin Fournier1, Christelle
Laurensou2, Ce´cile Aillaud2, Antoine Lafont1, Bruno Gogly1
1Inserm U849, Universite´ Paris-Descartes, Paris (France),
2Laboratoires URGO, Chenoˆve (France)
Matrix metalloproteinases (MMPs) activity increases in chronic wounds, lead-
ing to a metabolic imbalance slowing down the healing process. Mechanisms of
action of a new compound, Nano-Oligosaccharide Factor (NOSF), on wound
healing was studied in vitro. The aim of this work was to compare the eﬀects of
lipido-colloid dressings containing or not NOSF on the activity of MMPs.
Normal human dermal ﬁbroblasts were incorporated within a collagen matrix,
i.e. dermal equivalent (DE). Dressings were applied on DE, and the culture
medium was analysed at days 2, 4 and 8. MMP-2 and -9 (Gelatinases), MMP-3
(Stromelysin) or MMP-1 and -8 (Collagenases) activities were analysed using
zymography techniques with gelatin, casein and collagen gels, respectively.
At Day 4, NOSF clearly inhibited gelatinases (MMP-2 et -9) and collagenases
(MMP-1 et -8). Kinetic analysis of NOSF eﬀects demonstrated that the inhibi-
tion of gelatinases was slightly (MMP-9) or not (MMP-2) detectable at Day 2,
while the eﬀect existing at Day 4 persisted at Day 8. In contrast, concerning
collagenases, the inhibitory eﬀects of NOSF were detected as soon as Day 2 but
disappeared at Day 8.
Using a dermal equivalent made it possible to study the eﬀects of NOSF in vitro
but at tissue level, in a close to in vivo dressing application situation. The eﬀects
of NOSF on collagenases appeared rapidly but did not persisted while those on
gelatinases were delayed but were maintained longer. This study contributes to
explain the eﬃcient results of NOSF observed in vivo on chronic wounds.
Wound Rep Reg (2008) 16 A66–A82 c 2008 by the Wound Healing SocietyA74
Abstracts
Complications in the venous system in patients with diabetes
Raj Mani, Starla Yarde, Nurul Rashid, Geoﬀ Roberts and Puja Patel
Vascular Laboratory Services, Southampton University Hospitals Trust,
Southampton UK
It is commonly stated that venous insuﬃciency is a risk factor for the develop-
ment of diabetic foot disease. Analysis of the literature yielded little objective
evidence to guide us in this context. As common complaints of the venous sys-
tem are deep vein thrombosis (DVT) and venous insuﬃciency, we have studied
the point prevalence of these issues in our centre.
In a study on diabetics at risk of DVT, we recruited 175 patients who were
grouped as follows:
Group 1: Diabetics ‘at risk’ of DVT (n=33)
Group 2: Diabetics ‘not at risk’ of DVT (n=15)
Group 3: Non-diabetic patients ‘not at risk’ of DVT (n=127).
The point prevalence of DVT in Group 1 was 12.5% (90% CI) (6.6%–22.4%).
The point prevalence of DVT in Group 3 was 22.8% (90%CI) (17.3%–29.5%).
None of the diabetic patients ‘not at risk’ had DVT.
This study permits the conclusion that the diabetic patient is at less risk of get-
ting DVT than the cohort group.
A second study was done on the point prevalence of venous incompetence. Di-
abetics (n=75) with and without foot ulcers were tested for above knee venous
incompetence in both deep and superﬁcial venous systems, venous reﬁlling
times (VRT) as a measure of haemodynamic disease and arterio-venous re-
sponse as a measure of venous incompetence. The results yielded a prevalence
of deep venous incompetence of 64% and 70.7% in the right and legs respec-
tively, which is signiﬁcantly higher than a report on the general population
(po 0.05). 42.7% and 49.3% of subjects had reduced VRT in right and left legs
respectively. 30.7% and 33% of subjects had reduced AV response on right and
left legs respectively. These data permit the conclusions that venous incompe-
tence is high in the diabetic population who also exhibit haemodynamic dys-
function.
These ﬁnding provoked the question: should we investigate and treat the ve-
nous aspect of the peripheral circulation in diabetics to improve our under-
standing and perhaps management of diabetic foot disease?
Posttraumatic osteomyelitis: current treatment options and future
directions
Gerrolt N. Jukema
Department of Trauma Surgery, VU University Medical Centre, Amsterdam,
The Netherlands
Introduction: Chronic infected wounds, with little tendency to heal spontane-
ously, pose a continuing challenge in medicine. Despite various options for
treatment of such infected wounds, such as repeated surgical debridement and
antibiotic therapy, the condition cannot always be treated eﬀectively and can
result in prolonged and multiple hospitalizations. In some cases a ﬁnal solution
to cope with such wounds, for example severe posttraumatic osteomyelitis, may
be a disabling amputation. The process of wound healing is complex and nor-
mally proceeds through at least three stages. The ﬁrst, catabolic stage in a trau-
matic wound lasts from day 1 to day 5. The second stage lasts about two days,
from day 5 to day 7, and is called the proliferation or anabolic phase. During
this phase, fresh granulation tissue grows into the wound area. The last stage of
wound healing, the recovery stage, occurs when the ingrowth of ﬁbroblasts cre-
ates scar tissue. This ﬁnal stage may last until day 21 of the recovery. The nor-
mal process of wound healing may be disturbed at each stage by local or
systemic infection, be delayed by underlying conditions such as diabetes melli-
tus or by exogenous factors such as smoking. If the wound becomes colonized
by bacteria or even infected, production of lytic enzymes and toxins by micro-
organisms and the host inﬂammatory reaction impairs wound healing and
spontaneous wound closure is delayed even further. Many of these factors play
a role when infection progresses to involve underlying bone, resulting in osteo-
myelitis. For better knowledge for treatment of the infection, posttraumatic
osteomyelitis should be separated in acute onset osteomyelitis (clinical signs of
infection observed within 6 weeks after initial trauma or orthopaedic proce-
dure) and late, chronic osteomyelitis (clinical signs of infection after 7 weeks or
more after trauma or orthopaedic procedure.
Diagnostic Approach in posttraumatic osteomyelitis: In case of suspected post
trauma osteomyelitis, clinical examination for local signs of infection such as
painful swelling of soft tissues should be performed. Bacterial culture by sterile
aspiration of soft tissue ﬂuids or ﬁstula is needed to conﬁrm the diagnosis and
to identify the bacteria(s) causing the infection. Furthermore X Ray examina-
tion of the aﬀected bone in combination with CT-PET scan and/or MRI is
needed for visualization the extension of the soft tissue or bone infection.
Therapeutic approach in Osteomyelitis: Although the current standard surgical
approach to osteomyelitis, i.e., repeated debridement of necrotic tissue, lavage,
sequestrectomy or bone resections, complemented by antibiotics, can cure
acute post trauma osteomyelitis the infection in most cases, especially in
chronic osteomyelitis many cases can not be treated successful in curing the in-
fection or prevent prolonged or recurring hospitalization. Even after wound
closure, a risk of recurrence of infection remains, which may lead to re-hospi-
talization(s) and a prolonged time of healing. In severe cases segmental bone
resection followed by callus distraction can be useful to cure severe osteomyeli-
tis but patients compliance should be checked carefully in advance before such
treatment can be performed. Furthermore during the period of callus distrac-
tion many minor (e.g. pin tract infections) or major complications (e.g. delayed
or failed callus formation) can be observed. Therefore new therapeutic ap-
proaches like Vacuum Assisted Closure therapy, the new VAC Instill therapy,
and experimental Maggot Debridement Therapy (MDT) are used to today to
reduce the risk of invalidating amputations, especially in younger patients.
Conclusion: Despite modern concepts orthopaedic treatment for injured pa-
tients, there is still a risk on acute posttraumatic infection and osteomyelitis.
Although early surgical debridement and lavage in acute osteomyelitis can cure
the acute infection in combination with antibiotic therapy, late complications
can occur. If a patient suﬀers chronic osteomyelitis, there is a risk for recurrent
exacerbations, depending on contributing risk factors which can cause recur-
rent hospital admissions and, in worst case scenario’s disabling amputations.
Therefore consequent diagnostic and therapeutic approach is needed to reduce
these risks.
Novel lipase activity detected in induced Lucilia sericata excretions/
secretions
A. S. Andersen1,2,3, B. Joergensen2, T. Karlsmark2, M. J. A. van der Plas4, K.
A. Krogfelt1
1Statens Serum Institut, Copenhagen Dk,
2Copenhagen Wound Healing Center Dk,
3University of Copenhagen Faculty of Health science,
4University of Leiden, The Netherlands
Introduction: Maggot debridement therapy (MDT) is a controlled application
of commercially produced sterile larvae from the green bottle ﬂy L. sericata to a
wound in need of debridement. Many patients with chronic wounds are ideal
candidates for MDT. The maggots gently remove necrotic tissue by proteolytic
digestion during the 3 day application, leaving the healthy granulation tissue
unharmed. The composition of the maggot’s excretions/secretions (ES) is sub-
ject to worldwide research and an elucidation of the mechanisms behind MDT
will allow supplementations into other treatment regimes.
Methods: ES were collected from 1st, 2nd or 3rd instar level maggots subjected
to the diﬀerent inductions prior to ES collection. Starvation, feeding on a sterile
food source, external bacterial challenge with Staphylococcus aureus and for 3rd
instar maggots a 3 day patient treatment induction. ES samples from diﬀerent
inductions with total protein amounts of 50mg and 100 mg was subjected to en-
zyme activity screening assays using a Crystal violet fatty acid lipase activity
assay.
Results: Lipase activity was detected in all samples however, the highest activ-
ities compared to the addition of a puriﬁed commercial lipase were detected in
the 3rd instar and patient induced ES.
Conclusion: To the authors knowledge this is the ﬁrst report of diﬀerentially
induced lipase activity in ES. Lipolytic activity may play a role in the mecha-
nisms of larval feeding in MDT, especially in the late stages of the therapy;
however whether this activity originates from the excretions or secretions of the
maggots is subject to further research and identiﬁcation.
The use of acellular, radiation-sterilized amniotic membrane increases
healing rate of hard-to-treat chronic venous leg ulcers
Tomasz Grzela1,2, Artur Kaminski3, Iwona Radziejewska-Choma2, Robert
Brawura-Biskupski-Samaha1, Malgorzata Litwiniuk1, Tomasz Szular2, Maciej
S. Kielbinski2
1Department of Histology and Embryology, Medical University of Warsaw,
2Center of Phlebology, Warsaw,
3Department of Transplantology and Tissue Bank, Medical University of
Warsaw
The amnion is a tissue forming the innermost layer of fetal membranes and
placenta. Due to speciﬁc composition, amniotic membrane is an ideal surface
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for cell migration and diﬀerentiation. Moreover, amnion components may dis-
play anti-inﬂammatory/immunosuppressive activity. The properties of the am-
niotic membrane make it an attractive dressing material. Its current clinical
applications include treatment of severe skin burns and ocular surface, pleura
or pericardium reconstructions. Also, some attempts to use the freshly isolated
amnion for chronic wound management have been undertaken. However, the
use of freshly isolated material is limited. Therefore, various procedures of
preparation, sterilization and storage of amnion samples have been developed,
but their clinical eﬀectiveness requires further veriﬁcation.
The aim of study was to assess the inﬂuence of acellular, gamma-irradiated
amnion samples on hard-to-treat chronic venous leg ulcer in 38 patients. The
study procedure included once-per-week Bates-Jensen questionnaire-based
wound assessment, digital planimetry, and application of the respective dress-
ing and two-layer compression of the aﬀected leg. After four weeks of treatment
individuals displaying re-epithelialization rate o 10% per week were qualiﬁed
for a further treatment with the amnion dressing (n=22). The remaining 16
patients (control group) received previous treatment. After next four weeks in
amnion-treated group the re-epithelialization rate signiﬁcantly increased
(4.89 1.07 to 11.86 1.70; P=0.00001), whereas in control group it remained
unchanged (12.24 1.42 to 12.55 2.18; NS). The observed diﬀerencemay result
from biologically active factors in amnion samples, as veriﬁed by western-blot.
The acellular, radiation-sterilized amnion could be a valuable dressing supple-
ment especially useful for hard-to-treat chronic venous leg ulcers.
A novel vitronectin: growth factor complex for treatments of wounds
Zee Upton
Tissue Repair and Regeneration Program, Institute of Health and Biomedical
Innovation, Queensland University of Technology, Brisbane, Queensland,
Australia
Topical administration of growth factors has displayed some potential in
wound healing, but variable eﬃcacy, high doses and costs have hampered their
implementation. Moreover, this approach ignores the fact that wound repair is
driven by interactions between multiple growth factors and extracellular matrix
proteins. We have discovered, however, that complexes comprised of insulin-
like growth factors (IGF) and IGF-binding proteins bound to the extracellular
matrix (ECM) protein vitronectin (VN) signiﬁcantly enhance cellular functions
relevant to wound repair in human skin keratinocytes in 2D and 3D in vitro cell
models and are active, even in the presence of wound ﬂuid. Moreover, these
responses require activation of both the IGF receptor and the vitronectin-bind-
ing av integrins. Further, we have assessed the complexes as a topical agent in
the treatment of deep partial thickness burns in a porcine model. This has re-
vealed that the complexes hold promise as a wound healing therapy. Critically,
the signiﬁcant responses observed in vitro and the encouraging data in vivo were
obtained with nanogram doses of growth factors. This suggests that coupling
delivery of growth factors to ECM proteins such as VNmay ultimately prove to
be a more eﬀective strategy for developing a wound healing therapy. In light of
this encouraging data we have manufactured the components to GMP stan-
dard, completed toxicity testing and a clinical trial examining the potential of
these novel complexes as a treatment for venous and diabetic ulcers will com-
mence in March. Our progress towards this trial, as well as the development of
new second generation growth factor: VN chimeric protein mimetics, will be
presented
Controlling sprouting angiogenesis – a tale of leaders and followers
Holger Gerhardt
Vascular Biology Laboratory, London Research Institute – Cancer Research
UK, Lincoln’s Inn Fields Laboratories, PO Box 123, London, WC2A 3PX,
United Kingdom
Endothelial cells within the angiogenic sprout need to coordinate their behavi-
our and cellular functions during sprout induction, elongation and lumen for-
mation, as well as during subsequent branching and anastomoses. Initial sprout
induction involves selection of a leading tip cell, which will then guide the
growing sprout by reading attractive and repulsive guidance cues provided by
the surrounding tissue environment. A regular vascular patterning is achieved
by coordinating the balance of tip-cell migration and stalk cell proliferation.
The graded distribution of heparin-binding isoforms of VEGF-A is instrumen-
tal for this balance: The steepness of the gradient regulates the speed of tip cell
migration, whereas the local concentration reaching the stalk-cells gauges their
proliferation1,2. Recent studies illustrated that VEGF-A is responsible for in-
duction of the sprouting response, whereas Dll4 signalling through Notch1 reg-
ulates which cell will become the tip cell and which cells will constitute the
trailing stalk cells3,4. Genetic and pharmacological inhibition of endothelial
Notch signalling results in excessive ﬁlopodia formation and tip cell activity in
all endothelial cells exposed to the inductive stimulation through VEGF-A.
Conversely, ectopic activation of Notch signalling leads to rapid reduction in
ﬁlopodia formation and sprouting activity, resulting in reduced vascular den-
sity in the ensuing plexus. These studies illustrated that the tip cell response is
the default answer to VEGF-A stimulation, whereas the stalk cell phenotype is
an acquired function dependent on cell autonomous Notch activity. Computer
simulation of the tip-cell selection process indicated that the VEGF-A gradients
facilitate stable selection and that the ﬁlopodia extension confers robustness to
this system5. These observations on the regulation of tip and stalk-cells estab-
lish two fundamental principles in angiogenic sprouting: vascular patterning
can be achieved 1) by balancing the migration of tip-cells to the rate of prolif-
erating stalk-cells through VEGF-A gradients, and 2) by regulating the num-
bers of tip- versus stalk-cells through modulation of the Dll4/Notch signalling
pathway involved in tip-stalk selection.
The meaning of skin injuries and their surgical reconstruction: ﬁrst long
time experiences with the collagen-elastin matrix Matriderm as a
dermal substitute in severe burn injuries of the hand
L.P. Kamolz, D.B. Lumenta, W. Haslik, M. Frey
Vienna Burn Centre, Division of Plastic and Reconstructive Surgery,
Department of Surgery, Medical University of Vienna, Austria
Skin has a important concrete physiologic role, but beside its physical func-
tions, it has also a massive psychological meaning: skin is the part of us that
comes into contact with what is outside of us and it gradually enables us to get
to know the world, but it also sets the boundary between us and the other ob-
jects in the world. Think, then, what happens to a person who suﬀers a sudden
skin injury: The sense of invasion or leakage in the part that holds, protects,
unites and distinguishes the individual as a unique human being is liable to cre-
ate a whole set of feelings of disintegration and existential fear.
In burn injuries this is often accompanied by a real danger due to the serious
physical condition, which includes loss of ﬂuids, risk of infections, the need for
artiﬁcial respiration, repeated surgical intervention and much more, all result-
ing in helplessness and fear of death. In addition, because injury to the body
cover also damages the person’s appearance, that is, his body image, the neg-
ative feelings are also accompanied by confusion and problems with the self-
identity. This is particularly severe when visible parts of the body, especially the
face and hands, are involved, because self-perception and physical image are a
result of continuous mutual reﬂections between us and the social world. It can
be said, that a person with a burn injury not only experiences a sense of disin-
tegration and confusion regarding identity, but also feels anxiety regarding his
or her place in the social world. A very important part in the healing process is
the patient orientated surgical treatment. One of the main surgical objectives is
to achieve an earliest possible, durable and mechanic stable coverage of the
burn wounds, but due to the improvements in burn wound treatment, not only
survival, but also regained quality of life plays an important part of the ﬁnal
outcome.
Great eﬀorts have been made in the past to develop artiﬁcial replacements of
dermis and epidermis to overcome the problem of poor skin quality and scar
contraction in order to achieve optimal function and aesthetic appearance of
the restored and reconstructed skin. Thereby, optimal skin reconstruction plays
a very important role in regaining quality of life after burn injuries. Thereby the
reconstructed pliability of the grafted areas is of utmost importance for good
hand function. The collagen elastin matrix Matriderm was evaluated as a der-
mal substitute for the treatment of severe hand burns.
In a series of 10 patients, mean age 43 years, TBSA 22.8%, an early debride-
ment and immediate grafting with the matrix and unmeshed skin graft was car-
ried out in a one-stage procedure. In the early postoperative follow up an
overall take rate of 97% was observed. In contrast to conventional skin grafts,
the colour of the skin grafts over the matrix appeared pale in the ﬁrst few days,
but after 2 weeks no diﬀerence was observed. After three months, pliability of
the grafted area was excellent, (mean VSS 3.2 1.2). Full range of motion was
achieved in all hands, no blisters and no unstable or hypertrophic scars oc-
curred. These good functional and aesthetic results remained stable, even after
the one year follow up.
Matriderm has proved to be a dermal substitute suitable for the treatment of
hand burns. We therefore consider Matriderm as a promising dermal substitute
for the treatment of severe hand burns.
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A 15 year landscape on culturing skin cells for burns patients
Professor Sheila MacNeil
Professor of Tissue Engineering, Department of Engineering Materials,
University of Sheﬃeld
Since the early 90s my group have been delivering laboratory expanded cul-
tured autologous keratinocytes for the treatment of patients with extensive
burns injuries, initially as cultured epithelial autografts (CEA) and more re-
cently on a carrier membrane. A 10 year audit of the clinical use of CEA iden-
tiﬁed major problems in timing the production of these integrated cell sheets to
the needs of the patients. Accordingly we then developed a chemically deﬁned
plasma polymerised surface containing 20% carboxylic acid groups from which
to deliver the cells to the patients. Taking this approach forward so that it was
sustainable rather than dependent on research funding was tackled by estab-
lishing a spin out company, CellTran Limited in 2000.
The ﬁrst product (available in the UK since 2004 asMyskin) was used to deliver
cells for burns patients and for patients with chronic non-healing diabetic foot
ulcers. Supplying the cells in easy to handle polymer discs obviates the necessity
of the surgeon or nurse handling spray-on cells or fragile sheets of cultured cells.
Crucially it also gives a much more ﬂexible timing of delivery of cells to patients
as cells are now expanded in the laboratory and then only transferred to the
discs 2 days prior to application of the cells on discs to the patients. More re-
cently the company in May 2008 received approval from the Department of
Health to supply allogeneic screened keratinocytes on a plasma carrier dressing
available from frozen for treatment of patients with partial thickness burns.
From 1994 we have also been involved in the bigger challenge of making 3D
reconstructed skin to replace or augment split-thickness skin grafts. Initially
this used human allodermis and more recently we have progressed to a biode-
gradable synthetic electrospun scaﬀold. Early pilot clinical results identiﬁed
problems of delayed angiogenesis and tissue engineered skin graft contraction.
Accordingly in recent years, our in vitro research has concentrated on getting a
better understanding of the problems of neovascularisation and of reducing
contraction in tissue engineered skin. These remain major challenges in devel-
oping tissue engineered skin to beneﬁt burns patients.
Development of a novel dermal substitute based on glycerinised
allograft
A. Pirayesh, C.D. Richters, H. Hoeksema, J. Vanoorbeek, H. Hoekstra,
S. Monstrey
University Hospital Gent, Gent, Belgium; Euroskinbank, Beverwijk, The
Netherlands; Burn Research Institute, Beverwijk, The Netherlands
Introduction: The Quest remains for an optimal and cost-eﬀective dermal sub-
stitute (DS) which improves the outcome of split skin grafted (SSG) defects.
Skin restoration with a dermal substitute and a thin SSG signiﬁcantly reduces
scarring, contracture and donor morbidity compared to SSG alone. Currently
available dermal substitutes remain controversial due to variable take rates,
susceptibility to infection and high costs. No valid monitoring modality has yet
been reported to gage the ingrowth of the DS and elucidate the optimal time for
SSG application. We developed a prototype derived from human glycerinized
allograft by processing in low concentrations of NaOH and assessed it’s eﬃcacy
in a porcine wound model and an initial phase 1 clinical study in 12 patients
with full thickness burn defects.
We initiated monitoring of the DS with Laser Doppler Imaging (LDI is a val-
idated tool for burn depth assessment) that can delineate vascularization of the
DS and optimal time for SSG engraftment.
Methods: 120 full thickness wounds of 4 4 cm were created on the ﬂanks of 15
pigs. One-Stage Procedures: wounds were engrafted with NaOH-DS and SSG
and controls engrafted with SSG only or in combination with AlloDerm or an
artiﬁcial collagen matrix. Two-stage procedures: wounds were randomly en-
grafted with NaOH-DS or Integra and subsequently engrafted with SSG after 7
days. Outcome was assessed by digital imaging, planimetry and punch biopsies.
Clinical Study: 12 full thickness burn wounds in 12 patients were engrafted in a
two stage procedure (one week interval). DS ingrowth was monitored by LDI.
Results: Wounds with prototype and SSG showed less contraction compared to
controls with a higher quality neodermis. SSG survival in one stage procedure ap-
proached only 65% for wounds engrafted with prototype or Alloderm, due to de-
layed vascularization as seen on histology. Two stage procedure takes of NA-OH
DS approached 85% comparable to controls engrafted with SSG only or Integra.
Contraction rates were signiﬁcantly lower in wounds with DS and SSG (po 0.05)
than those with SSG alone and comparable to Integra and SSG engraftment.
Clinical take rates of the prototype approached 95% in 12 patients.
Discussion: A viable, cost-eﬀective Dermal Substitute can be procured from
decellularised, glycerinized allograft. Most favorable results were obtained in a
two stage procedure. Emphasis is placed on initial clinical application of the
prototype including the use of LDI for monitoring purposes. These promising
results prompt us to advocate Glyaderm for dermal substitution. Ongoing
comparative clinical trials and multicentre protocols are discussed which in-
clude web-based multicentre interactive database, objective scar assessment and
paired intra-individual comparison.
Characterization of the engraftment of autologous keratinocytes
cultured on hyaluronan scaﬀolds on deep burns: clinical-histological
correlations
Franco Bassetto1, Giorgio Pietramaggiori,1,2 Paola Brun3, Barbara Zavan,3
Bruno Azzena,1 Giovanni Abatangelo,3 Dennis P. Orgill,2 Francesco
Mazzoleni1
1Division of Plastic Surgery, University of Padua, Italy,
2Division of Plastic Surgery, Brigham and Women’s Hospital, Harvard
Medical School, Boston, MA,
3Department of Histology, Microbiology and Medical Biotechnologies,
University of Padua, Italy
Background: Among the treatment options available for deep and extensive
burns, autologous keratinocytes cultured on hyaluronan scaﬀolds (CEA-
HYAFF-11s) are clinically used yet their engraftment is sill poorly characterized.
Objective: To characterize the engraftment of CEA-HYAFF-11s on deep
burn wounds.
Methods: In this clinical trial, CEA- HYAFF-11s sheets were grafted on deep
second degree-third degree burn wounds. After early excision, wounds were left
(1) spontaneously granulating, (2) grafted with autologous skin mesh grafts or
(3) grafted with allogenic cadaver skin followed by dermoabrasion. Each area
was treated with (experimental) and without (control) CEA- HYAFF-11s, and
clinical and histological descriptions were made.
Results: Although CEA- HYAFF-11s grafted wounds showed an early clinical
improvement compared to non treated wounds, histological specimens did not
show signs of epithelial engraftment during the ﬁrst week. Evidence of engraftment
of CEA- HYAFF-11s ﬁrst appeared two weeks post grafting with a newly syn-
thesized, linear basal laminawhile non graftedwounds were still mainly raw. From
the results we identiﬁed distinct phases in CEA- HYAFF-11s engraftment start-
ing from survival to adhesion and terminating into terminal engraftment. CEA-
HYAFF-11s engraftment increased re-epithelialization compared to controls also
on meshed autologous skin grafts and allogeneic, dermoabraded skin, with the
latter being the more reliable substrate for keratinocyte taking.
Conclusions: CEA- HYAFF-11s appeared to be a reliable resource for the
treatment of burns wounds especially when limited donor sites make auto-
logous skin transplantation diﬃcult. Areas of engraftment showed linear basal
lamina as a distinctive feature compared to spontaneous re-epithelialization.
Update on clinical wound care and burn treatment
Prof S. Monstrey
University Hospital Gent, Gent, Belgium
Improved resuscitation techniques and optimal treatment in specialized burn cen-
tres have resulted in increased survival of patients with extended and deep burns.
Nowadays, emphasis in burn treatment is shifting towards reducing scar tissue
formation.
Anti-scar therapies in burn patients should not only be started after the healing
of the burn wound, but already be considered from the time of the injury on.
Indeed, cooling of acute burns can make the diﬀerence between a superﬁcial
and a deep second degree burn, thus avoiding scar formation. Adequate sys-
temic ﬂuid therapy can prevent secondary deepening of burn wounds by im-
proving microcirculation in zones of stasis. An exact assessment of burn depth
(and the indication to operate) can be provided with a Laser Doppler Imaging
(LDI) thus avoiding unnecessary scar formation caused by grafting superﬁcial
wounds or prolonged conservative treatment of deep burn wounds.
The local treatment of burn wound should provide an optimal environment for
wound healing and reduce all inﬂammation while additional (and new) anti-
infection therapies (silver, iodine, honey) might be required to avoid infection
and the risk of deepening of the burn wounds.
Surgical therapy can inﬂuence the resulting scar through a precise indication for
escharotomy and grafting, by the judicious use of meshed grafts and Meek ex-
pansion and by the application of dermal substitutes or ﬂap surgery. Physical
therapy can inﬂuence early scar formation and local anti-scar therapies such as
pressure garment and silicone application are applied in various forms to im-
prove the ﬁnal scars. Skin hydration and moistening can help to keep the scars
supple and prevent itching while sun blocks protect against UV radiation and
secondary pigmentation.
An update will be provided on all recent strategies to further improve function
and aesthetics of scar formation after burns.
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Eﬀect of diﬀerent therapies on inﬂammation, itch and nerve
regeneration in a porcine scald wound model
L. P.E. van der Steen1, N.J. Paauw1, M.M.W. Ulrich2, E. Middelkoop2,
R.H.J. Beelen1, C.D. Richters1,2
1Dept Molecular Cell Biology & Immunology, VUmc, Amsterdam, The
Netherlands,
2Association of Dutch Burn Centres, Beverwijk, The Netherlands
Eﬀects of several treatments for partial thickness scald burns have been de-
scribed but there are few data available on the mechanisms of action. Especially
nerve regeneration and itch have only occasionally been studied although data
emphasizing the role of the nervous system in wound healing are increasing.
We have studied the eﬀects of 3 diﬀerent treatments in a standardized model
using Duroc pigs; Silver Sulfadiazine cream (SSD), Glycerol preserved all-
ogeneic skin (GPS) and a hydroﬁbre dressing (Aquacel). Wounds were made by
applying hot water (80 1C) for 20 sec on the ﬂanks of the animals and were cov-
ered with the diﬀerent dressings (N=9 wounds per type of dressing). The in-
ﬂammatory response and nerve outgrowth were studied on sections of biopsies
of day 3, 7, 14 and 56 after wounding. Contraction was measured using plan-
imetry at day 56. Itching behavior was recorded using a digital camera.
The macrophage inﬂux was the highest at day 7 but there were no signiﬁcant
diﬀerences between the treatments. The outgrowth of the epidermis was signiﬁ-
cantly faster in the wounds treated with GPS. There were no signiﬁcant diﬀer-
ences in wound contraction at day 56 but the wounds treated with SSD had
thicker scars compared to wounds treated with GPS or Aquacel. The latter
wounds showed also hyperkeratosis. The animals treated with SSD had up to
35% higher scores for itching behavior. First results using speciﬁc antibodies
for nerve ﬁbres suggest a delay of outgrowth of the nerve ﬁbres in the wounds
treated with SSD.
Biodegradable poly-n-acetyl glucosamine (pglcnac) nanoﬁbers enhance
wound healing by activating cell migration, angiogenesis and cell
proliferation
Sandra Saja Scherer,1,2, Giorgio Pietramaggiori1,3, Jasmine Matthews1, Samuel
Perry1, Anke Assmann4, Arun Seth5, Marina Demcheva6, John N. Vournakis5,
C. Robert Valeri7, Herbert B. Hechtman8 and Dennis P. Orgill1
1Division of Plastic Surgery, Brigham and Women’s Hospital, Harvard
Medical School, Boston, MA,
2Plastic and Reconstructive Surgery, BG-Unfallklinik Ludwigshafen,
University of Heidelberg,
4Plastic and Reconstructive Surgery, University hospital of Geneva, Geneva,
5Department of Laboratory Medicine and Pathobiology, University of
Toronto, Canada,
6Marine Polymer Technologies, Danvers, MA,
7Naval Blood Research Laboratory, Inc., Boston, MA,
8Department of Surgery, Brigham and Women’s Hospital, Harvard Medical
School, Boston, MA
Introduction: The clinical usage of tissue regenerative templates to treat tissue
defects is still limited because of delayed revascularization of matrixes leading
to infection and rejection. We have recently shown that biodegradable, diatom-
derived, haemostatic poly-N-acetyl glucosamine (pGLCNAc) nanoﬁbers in-
duce a marked increase in cell proliferation and angiogenesis in diabetic
wounds in mice. Here we developed a modiﬁed biodegradable short ﬁber Poly-
N-acetyl glucosamine (sNAG) to overcome present limitations of clinically
used skin substitutes.
Objective: We test the cellular mechanism of action of sNAG on cells in vitro
and the ability of sNAG-scaﬀolds to lead tissue regeneration in an experimental
diabetic wound healing model.
Methods: sNAG eﬀects on cell metabolism and migration where tested in vitro
assays. In vivo, full thickness wounds of db/db mice (n=15 per group) were
treated either with a NAG-scaﬀold (NAG-scaﬀold), or were left untreated
(NT). Macroscopic wound healing kinetics, granulation tissue formation, cell
proliferation (Ki67), angiogenesis (PECAM-1), migrative activity (MAP-Kin-
ase), keratinocyte migration (p63) were monitored over a study period of 28
days. mRNA levels related to migration (uPAR), angiogenesis (VEGF), in-
ﬂammatory response (IL-1b) and ECM remodeling (MMP3 and 9) were mea-
sured in wound tissues on day 10.
Results: sNAG enhanced cell metabolism, endothelial and ﬁbroblast migration
in vitro. NAG-scaﬀold produced faster wound closure compared to controls
mainly by re-epithelialization. sNAG treated wounds showed increased kera-
tinocyte migration, granulation tissue formation (2.8 fold), cell proliferation
(4fold) and vascularization (2.7fold) compared to NT wounds. mRNA levels
related to angiogenesis (VEGF), cell migration (UPAR) and ECM remodelling
(MMP3, MMP9) were upregulated in NAG-scaﬀold treated wounds compared
to NT wounds.
Conclusions: The nanoﬁber pGLcNac based scaﬀold enhanced wound healing
mainly by re-epithelialization and angiogenesis. This eﬀect was likely lead by
speciﬁc cell - ﬁber interactions leading to revascularisation and integration of
the scaﬀold. The introduced polymer nanoﬁber material is a potential candi-
date to overcome existing limitations of regenerative templates for the treat-
ment of tissue defects.
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POSTER 1
New therapeutic approach in the treatment of severe radiation burn:
surgery and local stem cell therapy
Prat M., Bey E., Brachet M., Trompier F., Ernou I., Boutin L., Gourven M.,
Tissedre F., Cre´a S., Ait Mansour C., de Revel T., Carsin H., Gourmelon P.,
and Lataillade J-J.
The therapeutic management of severe radiation burns remains today a chal-
lenging issue. The conventional surgical treatment (excision and skin autograft
or ﬂap) often fails to prevent unpredictable and un-controlled extension of the
radiation necrotic process.
We report here our second experience of therapeutic management of a radiation
accident victim combining surgery and cellular therapy using autologous Me-
senchymal Stem Cells (MSC).
The patient presented a very severe arm radiation burn which was treated by
several surgical times: iterative excisions, skin graft, latissimus muscle dorsi ﬂap
and forearm radial ﬂap). Local autologous MSC were administrated as an ad-
juvant to improve the surgical approach. The clinical evolution (radiation pain
and healing progression) was favourable and no recurrence of radiation inﬂam-
matory waves was observed during the eight month patient’s follow-up sug-
gesting that MSC act as ‘‘cell drug’’ in modulating radiation inﬂammatory
processes.
These results open new prospects in the medical management of severe radia-
tion burns.
POSTER 2
Cell regeneration therapy as an adjunct to healing in recalcitrant
wounds
Cairns S.A., Leaper D.J., Harding K.G.
Department of Wound Healing, Cardiﬀ University, Wales
Background: Chronic wounds have for many centuries represented a major
source of morbidity and mortality in patients. In the modern era we realise that
these wounds also produce a major psychological impact to the patients, and a
ﬁnancial burden to the healthcare systems around the world.
Ever since the ﬁrst skin grafts were attempted in India around 2000bc for the
reconstruction of punitatively amputated noses, the surgical profession and
medical sciences have been searching for the panacea to treat chronic wounds.
Yet as our understanding of the aetiology of chronic wounds deepens we realise
that the varied nature of the wound pathogenesis means there will never be a
‘‘one cure for all’’ treatment. In this way we can see that a split skin graft is
certainly not the optimal option for many patients, and that alternatives must
be found.
Method: In two selected patients with chronic static laparotomy wounds we
demonstrate the successful use of a biological tissue regeneration therapy (Ap-
ligrafs) in the management of these recalcitrant wounds.
Conclusion: In carefully selected patients under the care of a Multidisciplinary
Wound Healing Team, the use of cell based tissue regeneration products may
provide a valuable adjunct to standard wound healing regimens.
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POSTER 3
Deep venous incompetence in patients with diabetes mellitus: a case
control study
Starla Yarde, Puja Patel, Geoﬀ Roberts, and Raj Mani
Vascular Laboratory Services, Southampton University Hospitals Trust,
Tremona Road, Southampton, UK
Introduction: Venous hypertension has been suggested to be a risk factor for
diabetic foot disease. This is considered to the eﬀect of autonomic neuropathy
though this appears to be based on clinical evidence. It has also been reported
that diabetics with neuropathy have impaired venous function and haemody-
namic dysfunction. Deep venous incompetence causes venous hypertension and
haemodynamic changes. The prevalence of deep venous incompetence in the
diabetic population is largely unknown. This aim of this study was to determine
the prevalence of deep venous incompetence in the diabetic population in
Southampton since as diabetic foot disease is a major problem.
Methods: This study was a case-controlled study at the Southampton General
Hospital. The study included two groups of subjects recruited from Diabetic
Foot Centre that is a referral point for diabetic care including foot disease. Pa-
tients were subdivided in to groups.
’ Group 1 – The diabetic patient with frank ulcers or healed ulcers.
’ Group 2 – The diabetic control subject with no foot ulcers.
Each patient underwent a duplex ultrasound scan to measure venous reﬂux for
deep venous incompetence and laser Doppler ﬂowmetry (LDF) scans. LDF
scans were done to determine the arterio-venous response (AVR) and the ve-
nous reﬁlling time (VRT) respectively. The data were analysed using the Pear-
son Chi square, Fisher’s exact and the Mann Whitney U tests. The study was
conducted with Ethics approval and prior informed consent of patients.
Results: 75 subjects were recruited and tested.
64% and 70.7% of diabetic subjects had deep venous incompetence in their right
and left legs respectively which is statistically signiﬁcantly greater (po 0.05) than a
previous report.
42.7% and 49.3% of subjects had a reduced VRT in the right and left legs re-
spectively.
30.7% and 33.3% of subjects had loss of the arterio-venous response in the
right and left legs.
The presence of symptoms was also recorded during the study.
Discussion: These data permit the conclusion that here is a high prevalence of
deep venous incompetence in subjects with diabetes mellitus in our practice.
Given that venous incompetence is reported to be a risk factor for diabetic foot
disease and the argument that venous disease impairs wound healing, should we
be treating this aspect of the circulation in the diabetic population who are at
known risk of foot disease?
POSTER 4
Intensive treatment of wounds in lower limb amputation surgery can
save a leg!
C. Naves, V. Brehm, P. Steenvoorde, P. P. Hedeman Joosten, S.A. da Costa
Department of Surgery, Rijnland Hospital Leiderdorp, The Netherlands
Trans- tibial amputations have less co- morbidity than trans- femoral amputa-
tions. There is more stability when sitting, rehabilitation is easier and, most im-
portant of all, patients will preserve more of their self esteem.
However, trans- tibial amputations wounds have a higher risk of infection than
trans- femoral amputations. Infection of the trans- tibial wound results in longer
hospital stay, another operation and can even lead to a trans- femoral amputation.
In our clinic we have a very intensive treatment scheme for amputation wounds.
This includes, amongst other techniques, frequent inspection of the wounds,
Maggot debridement therapy and Vacuum Assisted Closure therapy (VAC).
Using this scheme, our hypothesis is that we prevent patients from undergoing a
trans- femoral amputation.
In a prospective study, we investigated all lower limb amputations from Janu-
ary 2003 until January 2007. During this period, 67 patients underwent a trans-
tibial amputation. 51 of these 67 patients (76%) went home with a healed
wound, 6 patients died within 30 days of surgery and in 10 patients conversion
to a trans- femoral amputation was necessary.
When comparing these outcomes to the literature on lower limb amputations,
we ﬁnd that our intensive treatment scheme pays oﬀ. In our clinic we relatively
perform more trans- tibial amputations than primary trans- femoral amputa-
tions. Furthermore, our trans- tibial amputation wounds had a signiﬁcantly
higher healing rate than the wounds described in the literature (76% versus 44-
62%). Also, a smaller percentage of trans- tibial amputations is converted to a
trans- femoral amputation.
These results demonstrate that it is better to use an intensive treatment scheme
in order to save a leg, since it has a signiﬁcantly higher success rate!
POSTER 5
Platelet Rich Fibrin (PRF) for hard to heal ulcers in patients with
diabetic feet
Caroline Naves,1 Pascal Steenvoorde,1,2 Louk P., van Doorn MA2
1Department of Surgery, Rijnland Hospital Leiderdorp,
2Rijnland Wound Clinic, Rijnland Hospital Leiderdorp, The Netherlands
Platelets play two important roles in wound healing: hemostasis and initiation
of wound healing. After platelet activation and clot formation, growth factors
are released. In ordinary blood, the number of platelets is 0.2 106/ul. In con-
trast, it is 4 1.0 106/ul in platelet-rich plasma.
Autologous growth factors from concentrated platelet suspensions have been
used to treat wounds for years. The use of platelet-derived wound healing for-
mulae delivered in a crystalline collagen carrier was ﬁrst published in 1986.
The Vivostats System is a medical device for thepreparation of an autologous
ﬁbrin sealant from 120ml of thepatient’s blood. The system is fullyautomated
and microprocessor controlled and is made up of threecomponents: an auto-
mated processor unit, an automated applicatorunit, and a disposable, single-
patient–use unit, whichincludes a preparation set and a Spraypen applicator.
This pilot study of very hard-to-heal ulcers investigated whether treatment with
autologous platelet-rich ﬁbrin is feasible and to see if wound healing is im-
proved. We would like to discuss our results of application of PRF (Vivostat
PRF, Birkeroed, Denmark) in 8 treated patients with a diabetic foot ulcer.
Between September 2006 and November 2007 we recruited 18 patients with
chronic, hard to heal ulcera. All wounds were located on the lower limb. In our
population of 18 patients, there were 8 patients with a diabetic foot ulcer. 9
wounds were included in this study. (One of the patients had 2 wounds on the
lower limb which were treated simultaneously). The population consisted of 6
males and 2 females with a mean age of 55.3 years. (range 38–70). The mean
wound duration before treatment was 7.5 months (range 1–24).
The patients received a total of 23 treatments. In total, with a short follow up,
(1–24 months), over 60% of the wounds have closed. 2 wounds were smaller
than 1/3 of the initial size, although these are estimates only.
POSTER 6
A comparative study of the inﬂuence of diﬀerent pressure levels
combined with various wound dressings on negative pressure wound
therapy (NPWT) driven wound healing
Rey Paglinawan
Medela AG, Medical Technology, Lattichstrasse 4b, Baar, Switzerland
Introduction & Aim: To present date, although a number of studies have been
conducted to support the important role of NPWT in wound healing, none
have investigated the optimal pressure level intensity and manner of delivery of
negative pressure together with various combinations of existing dressing tech-
nologies. This study compared diﬀerent commercially available dressing types
in combination with a NPWT system used at various pressure levels. Wound
healing progression from these various parameters was subsequently assessed.
Methodology: Five pigs (Landras type) were allowed to acclimatize to the
housing conditions prior to all procedures. The animals were sedated, shaved
and scrubbed for surgery and transported to the operating room. Full thickness
wounds extending to the fascia over the deep back muscles (3.5 cm 3.5 cm,
maximal 10 per animal) were excised on each pig. Diﬀerent commercially avail-
able materials (foam, gauze, silver, textiles) were trimmed to the exact size of
each wound. Each wound site was sealed with a thin air-permeable adhesive
ﬁlm. The dressing system is then connected to a vacuum source which was set to
a diﬀerent level of negative pressure (10, 20, 30 kPa).
Result & Conclusion: Morphological and histological observations of our
wound porcine model indicate that healing is taking place independently from
the type of dressing used. Thus, providing insights that there is currently not
one type of dressing which is clearly outperforming the others when used in
combination with negative pressure therapy on porcine wound models.
Wound Rep Reg (2008) 16 A66–A82 c 2008 by the Wound Healing Society A79
Abstracts
POSTER 7
Correlation of physical properties and dressing design
J.M. Dillon, J.V. Clarke, A. Nicol
Department of Orthopaedics, Dumfries &Galloway Royal Inﬁrmary, Bankend
Road, Dumfries, UK
Aims: Wound problems such as blistering are common following total knee re-
placement (TKR) surgery. The physical properties of the wound dressings may
be responsible for this. They may not stretch to accommodate skin movement
and consequently transmit high levels of shear force to the skin.
Skin movement of TKR wounds was quantiﬁed and compared with the mate-
rial properties of a hydrocolloid, adhesive and two occlusive ﬁlm dressings.
Methods: TKR wound measurements were taken at 01, 301, 601 and 901 knee
ﬂexion in 85 patients. Percentage change in wound length at each ﬂexion level
was calculated.
The material properties of the dressings were quantiﬁed using an Instron 5800
uni-axial testing machine. Strain was calculated using grip to grip measure-
ments. Three samples of each dressing were tested.
Results: The traditional dressing showed very high loads for less than 5%
strain. The other three dressings extended to at least 25% strain with less than
10N load.
The hydrocolloid and both occlusive dressings extended the required amount to
accommodate skin movement (28% strain) with loads of 7.7N, 8.9N and 6.5N
respectively. The adhesive dressing extended to o 10% of the required amount
before reaching the limit of the 100N load cell.
Discussion: TKR wounds demonstrate dynamic morphology and strains of
over 20% with normal knee ﬂexion. Hydrocolloid and some occlusive dressings
exhibit suitable material properties to accommodate this skin movement but
traditional adhesive dressing do not. This may explain the high blister rates with
some dressings.
POSTER 8
LASER stimulation on ﬁbroblasts WI-26 based on photodynamic
processes
Fernando L. Primoa, Andreza R. Simionia,b, Bernard Coulombb and Antonio
C. Tedescoa,b
aDepartamento de Quı´mica, FFCLRP, Universidade de Sa˜o Paulo, Ribeira˜o
Preto, 14040-901 (Brasil),
bInserm U849. Universite´ Rene´ Descartes – Paris 5, Paris (France)
Phthalocyanines are interesting compounds for use in Photodynamic Process
(PDP) considering their high absorbance (680 nm), with optimal tissue pene-
tration by light. Chloroaluminium-phthalocyanine (AlClPC) is a photosensi-
tizer drug applied in the treatment of cancer and others no-oncological diseases
by PDP assay. The main goal of this work was to develop and study an AlClPC-
nanoemulsion to be used in combination with low energy LASER to modulate
cellular growth of ﬁbroblasts.
WI-26 ﬁbroblasts were used in vitro biostimulation studies in monolayer after
light application. The cells were incubated with AlClPC-nanoemulsion for 30
minutes in the dark, with later irradiated at 670 nm; at diﬀerent energy doses (24
hours and 48 hours) after nanocarrier treatment. Cellular viability was mea-
sured 3 and 5 days after irradiation using a MTT classical assay. Scratching
experiments to mimic the wound repair have been done using the same proto-
col.
Irradiation by low energy (1.0 to 5.0 J) stimulated cellular growth in a dose-
dependent manner, while the energy of 10 J showed a negative response for this
biostimulation. The results also showed that the biomodulation was time-de-
pendent, higher with a delay of 48 hours between dye and light application.
This protocol of PDP will know be used on in vitro reconstructed tissues to bet-
ter assess its eﬀect on the wound healing process.
POSTER 9
BITECIC (Biomaterials and Tissue Engineering Centre of Industrial
Collaboration) – A collaborative approach for creative partnerships
Claire Green
BITECIC Ltd, Thorpe Park, Leeds United Kingdom
Aim: To provide an insight into the BITECIC model and its methodology for
fostering productive collaboration.
BITECIC (Biomaterials and Tissue Engineering Centre of Industrial Collabo-
ration) was established in recognition of the need for a collaborative approach
to enhance the development of advanced clinical treatments and medical de-
vices in wound care and other medical specialisms. Developing creative part-
nerships by bringing together diverse expertise from an academic, clinical and
commercial perspective is at the heart of BITECIC’s way of working and con-
tributes to the development of novel therapies that meet clinical and commer-
cial expectations.
This collaborative approach will be of particular value in wound care, which
faces diverse and complex clinical and commercial challenges. The eﬀectiveness
of working in partnership with industry, clinicians and academics was illus-
trated by a recent project to determine the needs and opportunities in the area
of chronic wound infection. This example will be described in order to provide
an insight into the BITECIC model and its methodology for fostering produc-
tive collaboration.
BITECIC is committed to the development of solutions to real clinical needs. In
order to support this, BITECIC is working in collaboration with the Healthcare
Technologies Knowledge Transfer Network (Healthtech KTN) to develop the
Statements of Clinical Need (SOCN) initiative. This provides the infrastructure
to connect the industrialists, healthcare professionals and researchers who
comprise the UK Health Technologies community and to facilitate communi-
cation between these specialist groups. The SOCN project will be described and
delegates encouraged to participate.
POSTER 10
The eﬀects of nicorandil on wound healing (case series)
A.D. Riddell, D.J. Leaper, K.G. Harding
Wound Healing Research Unit Cardiﬀ University, United Kingdom
Introduction: We would like to report a series of nicorandil induced non-heal-
ing wounds seen over the past year.Nicorandil is a nicotinamide ester, and de-
rivative of synthetic nicotine. It functions as a potassium channel activator.
Uniquely Nicorandil has a nitrate group in its structure, adding venodiliatation
to its eﬀects. Thus causing increased blood ﬂow in the coronary arteries and
decreasing preload, the eﬀects combining to form a highly eﬀective anti anginal.
The association of nicorandil use and oral/anal ulceration is now fairly well re-
cognised. Less well known are nicorandil’s association with para-stomal ulcer-
ation, and indeed its association with ulceration of the GI tract from mouth to
anus. More recently there have been increasing reports of nicorandil-induced
ulceration in parts of the body distant to the GI tract. We report a series of cases
seen in our wound healing clinics, consisting of, patients, with lesions ranging
from post surgical wounds to leg ulceration.
All these ulcers had a common clinical appearance: there was no visual evidence
of healing, all lesions were extremely painful, and all healed rapidly following
withdrawal of nicorandil.
Objectives: The aim of this work was bring to a wider audience our experiences
of nicorandil’s association with non healing wounds.
Methods: Patients included in the study were those who have presented to the
Wound Healing Outpatient Clinics’ of the Wound healing research unit at Car-
diﬀ university over the last 18 months. All patients were taking Nicorandil, and
had typical non healing painful wounds, which have resolved or moved rapidly
towards resolution following exclusion of Nicorandil from their treatment.
Results: The mechanism and incidence of the non-healing associated with
Nicorandil is currently unknown, and may or may not be associated with the
properties of arterial and venous dilatation. It had previously been assumed
that the nicorandil itself caused the ulceration being seen in the GI tract. We
would hypothesise that the eﬀects of nicorandil (either directly or via metabo-
lites) is not in causing Ulceration/Wounds, but in preventing the normal healing
mechanisms of healing in a pre-existing wound. Thus explaining why initially
non-healing GI tract ulcers were observed (as this is a common site of injury/
ulceration), but since then non-healing wounds, in other sites, and even post
surgically have been observed.
Conclusion: As the use of nicorandil increases these painful, debilitating, costly,
and yet easily treatable wounds will become more common and a high index of
suspicion is needed in any patient taking nicorandil, with any non healing
wound.
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A prospective trial of near-infrared spectroscopy (NIRS) as a
continuous non-invasive method of ﬂap monitoring following breast
reconstruction
Cairns SA1,2, Whitaker IS1, Barrett MD1, L Hiew1, Boyce DE1, Cooper
MACS1, Leaper DJ2
1Department of Plastic, Reconstructive and Burns Surgery, Welsh Centre for
Burns and Plastic Surgery, Swansea, UK,
2Department of Wound Healing, Cardiﬀ University, Cardiﬀ, United Kingdom
Background: In the UK, following mastectomy for Breast cancer, patients are
oﬀered a choice of reconstructions, up to and including myocutaneous ﬂap re-
construction. Arterial or venous embarrassment represents a major cause of
complications, often requiring intervention or resulting in total ﬂap failure. A
system to recognise impending problems would improve salvage rates. Near
Infra-red spectroscopy (NIRS) has previously been shown to be a reliable in-
dicator of tissue status in trauma.
Objective: This pilot study examines the use of NIRS as a tool to assist the cli-
nician as a means of monitoring myocutaneous ﬂaps following oncological re-
constructive surgery.
Methods: Nineteen patients having myocutaneous ﬂap reconstruction, either
as an immediate or delayed reconstruction, were enrolled into the study. Mea-
surements were made using the InspectraTM St02 monitor (Hutchinson
s), mea-
surements of tissue oxygen saturation (St02) and Total Haemoglobin Index
(THI). Measurements were taken prior to, during, and after the surgery; with
post-operative monitoring occurring continuously for 72 hours. Data were cor-
related with clinical outcome measures.
Results: Out of the nineteen patients, there were two complete ﬂap failures and
four complications requiring intervention. In these six cases, problems were
identiﬁed by either a signiﬁcant rise in the THI or drop in the St02. One pa-
tient’s data were unrecordable in recovery, and the patient was therefore re-
turned to theatre immediately for a salvage procedure, which was ultimately
successful.
Conclusion: The InspectraTM St02 monitor (Hutchinson
s) has proved to be a
useful aid in the clinical setting. While not replacing the need for experienced
and rigorous nursing care, we believe it can be a valuable and objective means
of assessing ﬂap viability.
POSTER 12
Wound diagnostics: can a single molecular marker concur with an
expert’s multifactorial assessment of wound healing status?
Sandra Hemmington1, Paul Davis1, James Schouten1, Mark Burnapp1,
Douglas Queen1,2, Pat Coutts2
1Mologic Ltd. UK,
2Toronto Wound Healing Centres, Canada
Aims: Diagnostic tests are needed to improve outcomes and health economics
in wound care. Ideally, a healing status indicator should provide the highest
level of diagnostic accuracy (normally available only from specialised centres of
excellence), regardless of the carer’s expertise.Mologic has developed a novel
rapid protease assay with an indicator molecule biased towards MMPs 9 and 8,
to indicate wound healing status. The aim of this study was to assess correlation
between the test result and expert clinician judgement.
Methods: Fluids from 10 randomly selected wounds judged to be healing were
collected onto swabs, which were stored and shipped to the UK at  80 1C.
Fluids from another 9 randomly selected wounds judged to be non-healing were
processed identically. Samples were coded to ensure blinding to wound identi-
ties. Extracts of the samples were assayed by conventional procedures for total
protein, MMP 8 and MMP 9 (commercial immunoassays) and with zymo-
graphy, as well as by the non-optimised prototype novel rapid assay. The re-
sults of all the tests were compared with each other and with the expert clinical
judgement.
Results: The prototype rapid assay results did not correlate with conventional
tests, but they did correlate with the expert judgement. 7 of 9 ‘‘non-healing’’
wound samples were protease positive. 7 of 10 ‘‘healing’’ wound samples were
protease negative and another 3 had reduced protease activity. Under these
particular prototype conditions/thresholds and clinical assessment criteria, a
sensitivity of 77% and speciﬁcity of 80% were achieved.
Conclusion: Appropriate assays can be tuned to correlate well with expert clin-
ical judgement. Further developments will improve correlation.
POSTER 13
Development of a novel growth factor formulation to maintain serum-
free and feeder cell-free culture of human embryonic stem cells
Sean Richards, Kerry Manton, Zee Upton
Tissue Repair and Regeneration Program, Institute of Health and Biomedical
Innovation, Queensland University of Technology, Kelvin Grove, Brisbane,
Australia
To realise the full clinical potential of human embryonic stem (hES) cells, cul-
ture methods that do not involve animal products or puriﬁed/non-deﬁned fac-
tors must be utilised. This requires removal of animal feeder-cells, serum and
any other animal-derived products.
We have utilised a subtractive proteomic approach to analyse the components in
culture medium that are produced by the feeder cell layer in the presence and absence
of hES cells. We have subsequently used this information to add select candidate
factors in recombinant form to develop a serum-free and feeder cell-free culture sys-
tem for hES cells. We have successfully cultured hES cell lines (BGV01 andHUES2)
for over 30 passages using this new serum-free and feeder cell-free formulation. The
mediumcontains lowosmolarityDMEM, glutamax, LiCl, b-mercaptoethanol, Lipid
concentrate, Trace elements, Activin-A, bFGF, AlbucultTM (recombinant human
albumin, Novozymes Biopharma UK Ltd.) and an in-house recombinant chimeric
protein called VitroGros (composed of domains of vitronectin linked to IGF-I).
We have shown by immunoﬂuorescence and FACS that hES cells cultured in this
serum-free and feeder cell-free culture system express the undiﬀerentiated cell-sur-
face markers SSEA4, TRA1-60 and TRA1-81 and the intracellular marker
Oct4. Real-time PCR analysis has revealed that the expression of UTF1, SOX2,
FOXD4, OCT-4 and Dppa by these cells does not change more than two-fold
compared to cells cultured in the presence of serum and feeder cells. Interestingly,
hTERT is down-regulated four-fold and REX1 is down-regulated 75-fold in the
cells grown in the serum-free and feeder cell-free system. REX1 has recently been
linked to increased diﬀerentiation potential; hence the down-regulation of REX1
in these cells may demonstrate their stable pluripotent status. We have recently
injected the cells into SCIDmice to observe their ability to form teratomas in-vivo
and will also present data from these studies.
In conclusion, our serum-free and feeder cell-free media formulation supports the
undiﬀerentiated growth of hES cells for over 30 passages and allows hES cells to be
cultured in xeno-free, fully deﬁned, synthetic media. The media developed in our
laboratory contains very few growth factors and these are used at concentrations
much lower than those previously published by others. This in turn substantially
reduces the cost of culturing these cells and makes large-scale hES culture for ther-
apeutic applications a realistic possibility for the ﬁrst time.
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Exploring the application of ultrasound technology in pressure ulcer
prevention – an international multidisciplinary team study
A. Moorhead1, C. Adams1, M. Stinson1, A. Porter-Armstrong1, E. Gardner1,
J. Donnelly2, S. Deegan3, J. Nixon4, D. Bader5, C. Lyder6
1Health and Rehabilitation Sciences Research Institute, School of Health
Sciences, University of Ulster, Northern Ireland,
2Belfast Health and Social Care Trust, RoyalHospitals, Belfast, Northern Ireland,
3Northern Ireland Medical Physics Agency, Northern Ireland,
4The Clinical Trials Research Unit, University of Leeds, UK;
5Department of Engineering, Queen Mary, University of London, UK,
6School of Nursing, University of Virginia, USA
Introduction: High frequency ultrasound (HFUS) can create real-time two-di-
mensional images of internal structures to examine the ﬁrst few centimetres
depth of sub-dermal soft tissue, thus may have the potential to detect tissue
changes in pressure ulcer prevention. However, there is no evidence on the re-
peatability of HFUS. This study aimed to investigate the inter- and intra-rater
repeatability of HFUS scanning.
Methods: In a laboratory based study, 24 healthy subjects (21 females, 3 males;
32.08 12.25 years; BMI 24.94 5.57) participated on two occasions, one day
apart. Consenting subjects had points marked (day 1 only) on both heels (lateral,
posterior andmedial aspects) and seating interface (coccyx, and left and right ischial
tuberosities) and scanned by a researcher, then repeated by a second researcher us-
ing aHFUS scanner. Both researchers were blinded to each other’s scanning.HFUS
images were quantitatively and qualitatively analysed blindly by two assessors.
Results: Qualitative visual analysis showed almost perfect agreement between
two assessors (0.88 kappa co-eﬃcient). Intraclass correlation coeﬃcients (ICCs)
conducted on pixel intensity summation quantitative results showed low inter-
and intra-rater repeatability (25% moderate or high ICCs; ICCZ0.6).
Conclusions: Although quantitative analysis showed low inter- and intra-rater
repeatability, qualitative analysis showed better agreement. In practice, clini-
cians qualitatively read the images, and visual analysis appears to be the gold
standard in HFUS interpretation. Quantitative methods of analysing HFUS
images require further exploration by industry, scientists and clinicians.
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The eﬀect of topical analgesics on human keratinocyte and ﬁbroblast
behaviour
Harris, K.L., Bainbridge, N.J., Jordan, N.R. and Sharpe, J.R.
Blond McIndoe Research Foundation, Queen Victoria Hospital, Holtye Road,
East Grinstead, West Sussex, RH19 3DZ
Background: The application of topical analgesics to the donor site of split-thick-
ness skin grafts has been proven to be an eﬀective method of pain management but
little is known about their eﬀects on wound re-epithelialisation. This study com-
pares the eﬀect of four analgesics on human keratinocytes and ﬁbroblasts and
whole skin explants in vitro to determine whether skin cell behaviour and subse-
quent donor site wound repair is aﬀected by topical application.
Methods: The eﬀect of diclofenac, bupivacaine, lidocaine and ketorolac were stud-
ied at concentrations between 10mM and 1nM. Their eﬀects on skin outgrowth
were investigated using an ex-vivo skin explant model. The in vitro proliferation of
cultured primary human keratinocytes and ﬁbroblasts was also measured.
Results: Keratinocyte outgrowth from the explant model was most inhibited by
diclofenac with a signiﬁcant reduction at 100mM (p=4 0.001). Diclofenac also
exhibited the strongest inhibitory eﬀect on cell proliferation especially keratin-
ocytes. Ketorolac was the most cytotoxic. Bupivacaine showed cytotoxicity in a
dose-dependent manner with only the very highest concentrations having a signiﬁ-
cant inhibitory eﬀect. Lidocaine showed no evidence of cytotoxicity at the concen-
trations tested in either the in vitro cell studies or the ex vivo explant model.
Conclusions: It is important to ensure that topical analgesics are not used for a
prolonged period at concentrations which inhibit cell growth as this may result
in a altered cell behaviour and decreased wound healing.
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